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The DNA damage response (DDR) coordinates DNA repair events and transiently arrests 
cell-cycle progression until DNA damage has been removed. If the damage is not resolved, 
cells can enter an irreversible cell cycle arrest called cellular senescence. In irradiation-
induced senescent cells a large fraction of persistent DDR markers are associated with 
telomeric DNA, both in cultured cells and in in vivo tissues.  
The aim of my PhD project was to investigate the mechanism underlying this 
phenomenon. I showed that persistent DDR activation has a causative role for the 
senescence-associated cell cycle exit and that a double-strand break (DSB) within 
telomeric repeats is inducing a more protracted DDR activation compared with a non-
telomeric one in human cells. The DDR persistency at telomeres is neither dependent on 
their heterochromatic state nor on TRF2 loss from telomeres during senescence 
establishment. Rather, TRF2 recruitment next to a DSB, in the absence of telomeric DNA, 
is sufficient to induce a more protracted site-specific DDR focus and to impair DSB repair 
in mouse cells. Ageing is associated with accumulation of markers of DDR activation. In 
terminally differentiated brain neurons from old primates, I observed DDR activation at 
telomeres that were not critically short. 
Taken together, these results strongly suggest that TRF2 inhibits DNA repair at broken 
telomeres, contributing to the accumulation of unrepaired, DDR-positive telomeres during 
ageing. This can in turn trigger cellular senescence and impair tissue homeostasis 
providing a mechanism for ageing also in non-proliferating tissues. 
Finally, I focused my attention on DICER and DROSHA-dependent DNA damage 
response RNAs (DDRNAs), novel components of the DDR machinery, which have been 
described to be necessary for DDR activation at DSBs. I showed that RNase A treatment 
as well as DICER or DROSHA down-regulation impair DDR activation at uncapped 
telomeres and that DICER and DROSHA may have a role in chromosomal fusions. 
Furthermore, in cells with dysfunctional telomeres, the inhibition of telomeric DDRNAs 
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using inhibitory oligonucleotide molecules with a complementary sequence can prevent 
DDR activation and senescent-associated cell cycle arrest.  
These data indicate that at uncapped telomeres, DDRNAs with telomeric sequences are 
generated and that they are necessary for DDR activation and chromosomal fusions.
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2.1 The DNA damage response (DDR) 
2.1.1 Different types of DNA damage 
The integrity and stability of the genome is essential for the survival of an organism. 
Genomic DNA is challenged with different types of DNA damage (Jackson and Bartek, 
2009). A major source of potential alterations in DNA is the generation of mismatches and 
small insertions or deletions during DNA replication. In addition cellular metabolism 
produces reactive oxygen species (ROS) such as superoxide anions, hydroxyl radicals and 
hydrogen peroxide derived from oxidative respiration and products of lipid peroxidation, 
leading to oxidative modifications of DNA. Also some spontaneous reactions can lead to 
hydrolysis of nucleotides, generating abasic sites, or deamination of cytosine, adenine, 
guanine or 5-methylcytosine, that are converted to uracil, hypoxanthine, xanthine and 
thymine, respectively. Among exogenous sources of DNA damage are the ultraviolet (UV) 
component of sunlight, ionizing radiation (IR) and various genotoxic compounds (Iliakis et 
al., 2003; Povirk, 1996; Rastogi et al., 2010). For example bleomycin is a glycopeptide 
antibiotic used also in cancer therapy, which once chelated to a metal ion, reacts with 
oxygen to produce superoxide and hydroxide free radicals that directly cleave DNA. 
Etoposide is an alkaloid derived from a plant toxin and inhibits DNA topoisomerase II 
preventing re-ligation of the DNA strands broken during DNA unwinding (Soubeyrand et 
al., 2010). 
DNA crosslinks is a covalent linkage between the two strands and can be generated by 
bifunctional alkylating agents, such as psoralens, but also by UV and IR (Deans and West, 
2011). Single-strand breaks (SSBs) are nicks in the sugar-phosphate backbone of one 
strand and can be caused by IR or ROS, while double-strand breaks (DSBs) are breakages 
of the sugar-phosphate backbone in both strands that can be generated when DNA is 
exposed to IR, radiomimetic drugs or ROS. They are also generated upon replication 
across a nick, as an intermediate of class switch and V(D)J recombination and as a result of 
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fork stalling following oncogene-induced replication stress (Di Micco et al., 2007; Soulas-
Sprauel et al., 2007). 
2.1.2 The DNA damage response pathway 
The DNA damage response (DDR) is that set of cellular events that include the checkpoint 
functions and the DNA repair actions (Polo and Jackson, 2011). In the presence of DNA 
damage, DDR arrests the cell cycle progression to impede the propagation of altered 
genetic information (the checkpoint function), while it coordinates DNA damage repair to 
maintain genome integrity. 
Powerful activators of the DDR are ruptures of the sugar-phosphate DNA backbone, 
leading to the exposure of single-stranded DNA or the generation of DSBs. These two 
types of lesions are sensed by specialized complexes that recruit and activate two large 
protein kinases, ataxia telangiectasia and Rad3-related (ATR) or ataxia telangiectasia 
mutated (ATM), respectively, at the site of the DNA lesion (Fig. 1) (Nam and Cortez, 
2011; Shiloh and Ziv, 2013). They are members of the phosphatidylinositol 3-kinase-like 
family of serine/threonine protein kinases and phosphorylate their substrates on a serine or 
threonine that is followed by glutamine, the S/TQ motif (Bensimon et al., 2010; Langerak 
and Russell, 2011). The recruitment of either of these apical kinases to the lesion leads the 
local phosphorylation in cis of the histone H2AX at serine 139 (named γH2AX), a key step 
in the nucleation of the DDR. Indeed it acts as a recognition mark for the retention of other 
DDR proteins at sites of DNA damage (Martin et al., 2009), establishing a positive 
feedback loop, and fuelling the spreading of γH2AX along the chromatin up to megabases 
(Iacovoni et al., 2010). This results in the formation of cytologically detectable nuclear 
foci, containing multiple copies of the DDR proteins. Staining of DNA-damaged cells with 
antibodies against γH2AX or other DDR factors accumulating at DNA damage sites 
generates a distinctive nuclear pattern of discrete bright foci. As foci detection reveals the 
number and the position of the DNA lesions within a cell, immunocytological staining is 
generally considered a highly sensitive and informative approach because it allows the 
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detection of even a single focus and therefore informs on the activation of a cellular 
response at the single-cell level. 
 
Adapted from (Sulli et al., 2012) 
 
Figure 1. The DNA damage checkpoint response cascade.  
DSBs are initially recognized by the MRN complex, while ssDNA is sensed by RPA and the RAD9–RAD1–
HUS1 (9-1-1) complex. These DNA damage sensors recruit the apical kinases ATM and ATR, which is 
bound by ATRIP. These in turn phosphorylate (P) the histone variant H2AX on Ser139 (known as γH2AX) 
to recruit other components of the DDR cascade such as MDC1, 53BP1, BRCA1. The diffusible downstream 
kinases CHK2 (mainly phosphorylated by ATM) and CHK1 (mainly phosphorylated by ATR) spread the 
signal to effectors such as p53 and CDC25. There are three possible outcomes, cell death by apoptosis, 
transient cell cycle arrest followed by proliferation after DNA repair, or cellular senescence. 
 
ATR exists in a complex with the ATR-interacting protein (ATRIP), both before and after 
exposure to stresses such as UV irradiation (Nam and Cortez, 2011). When single-stranded 
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DNA is exposed, the single-stranded DNA binding replication protein A (RPA) binds to it, 
generating a signal for ATRIP and ATR recruitment. In addition to ATR, several other 
protein complexes are recruited to ssDNA sites such as the RAD17- containing complex, 
which participates in the loading onto chromatin of the heterotrimeric 911 complex 
(constituted by RAD9, RAD1 and HUS1), and Claspin, a protein that is independently 
recruited to chromatin. ATR kinase activity is additionally boosted by the 911 complex 
and by topoisomerase II binding protein 1 (TopBP1), an amplifier of ATR kinase activity.  
In the absence of DNA damage, ATM is maintained in an inactive dimeric structure in 
which the kinase domain is physically blocked (Shiloh and Ziv, 2013). The introduction of 
a DNA DSB leads to a conformational change in the ATM protein that stimulates the 
kinase to phosphorylate serine 1981, causing the dissociation of the homodimer. Active 
monomeric ATM is recruited to DSBs via an interaction with the MRN (Mre11-Rad50-
Nbs1) complex that is rapidly recruited to the ends of broken DNA molecules and initially 
functions to facilitate holding the broken ends in close proximity. Then ATM 
phosphorylates many substrates, including NBS1 and the DDR mediators like p53 binding 
protein 1 (53BP1), the mediator of DNA damage checkpoint 1 (MDC1) and breast cancer 
1 (BRCA1). This phosphorylation events fuel a positive feedback loop facilitating the 
recruitment of additional ATM molecules to the DSB site (Bekker-Jensen et al., 2005; 
Stucki et al., 2005).  
Therefore, DSBs such as those generated by IR, primarily activate ATM, while RPA-
coated ssDNA, products of perturbed DNA replication, triggers ATR activity. However, 
during S and G2 phases, resection activity at DSBs generates ssDNA, that provides a 
suitable substrate for ATR activation (Jazayeri et al., 2006). 
Increase of local ATM and ATR activity determines phosphorylation of downstream 
protein kinases CHK2 and CHK1 respectively, although ATM can also phosphorylate 
CHK1 (Bekker-Jensen et al., 2006; Buscemi et al., 2004; Lukas et al., 2003). Activated 
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CHK1 and CHK2 diffuse in the nucleoplasm, phosphorylating their substrates throughout 
the nuclear space.  
In addition to phosphorylation events, other reversible post-translational modifications like 
ubiquitylation and sumoylation are essential for the DDR activation, especially in response 
to DSBs (Jackson and Durocher, 2013). In particular, the ubiquitin E3 ligase RNF8 
recognizes the phosphorylated MDC1 (Huen et al., 2007; Kolas et al., 2007; Mailand et al., 
2007) and mediates ubiquitylation of histones H2A and H2AX at the DSB site. The 
ubiquitylated substrates are then bound by another E3 ligase, RNF168 (Panier et al., 2012). 
This results in the recruitment of key components of the DSB repair pathways, among 
which 53BP1 and BRCA1 (Al-Hakim et al., 2010). 
2.1.3 Cell cycle and checkpoint activation  
In response to DNA damage, the cell activates a transient proliferative arrest in order to fix 
the lesion, before the following cell division. DDR regulates cyclin-dependent kinases 
(CDKs) that are responsible for cell cycle progression at key stages of the cell cycle 
(Branzei and Foiani, 2008; Malumbres and Barbacid, 2009). In particular, between the G1 
and S phases (G1/S checkpoint), within S phase (intra-S phase checkpoint) and between 
G2 and M phase (G2/M checkpoint).    
- The G1/S Checkpoint. Cell cycle progression is driven by phosphorylation events 
mediated by CDK4-CyclinD, CDK6-CyclinD, CDK2-CyclinE, and CDK2-CyclinA 
complexes that sequentially phosphorylate pRB. These complexes are maintained 
active through dephosphorylation by CDC25A phosphatase. In the presence of DNA 
damage, entry into S phase is prevented by the phosphorylation of CDC25A by 
CHK2, resulting in its inactivation by both nuclear exclusion and ubiquitin-mediated 
proteolytic degradation. In addition, ATM and ATR directly phosphorylate serine 15 
of p53, while the neighbouring serine 20 residue is phosphorylated by activated CHK1 
and CHK2. The phosphorylation of p53 inhibits its nuclear export and degradation, 
allowing p53 levels to greatly increase. The accumulated p53 activates its target genes, 
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including the gene encoding the p21 CDK inhibitor, which specifically binds to and 
inhibits the S-phase-promoting CDK2-CyclinE complex, thereby maintaining the 
G1/S arrest. 
- The intra-S phase checkpoint. The intra-S-phase checkpoint is activated by damage 
encountered by replication forks during the S phase or by unrepaired damage that 
escaped the G1/S. It can be initiated by the ATM/ATR-CHK2/CHK1-CDC25A-CDK2 
pathway, very similar to that activated for the G1/S checkpoint. A second pathway 
requires the phosphorylation of SMC1 by ATM with the aid of BRCA1, FANCD2 and 
NBS1.  
- The G2/M checkpoint. This checkpoint blocks the entrance in mitosis in the presence 
of DNA damage. ATM and ATR, through phosphorylation of CHK2 and CHK1, 
inhibit the entry into mitosis by down-regulating CDC25A and up-regulating Wee1, 
controlling CDK1-Cyclin B activity.  
Checkpoint activation in stem cells can have a dual role in cancer and ageing depending on 
the cellular context (Sperka et al., 2012). In the presence of high levels of DNA damage, 
deletion of checkpoint genes can improve stem cell and tissue maintenance, and at the 
same time also induce damage accumulation in cancer stem cells protecting from tumour 
initiation. Conversely, in a low DNA damage background, increasing the gene dosage of 
checkpoint genes can lead to improved clearance of damaged cells, prolonged tissue 
maintenance and decreased carcinogenesis. If the damage is not repairable, checkpoint 
activation can induce cell death by apoptosis or a permanent cell cycle arrest called cellular 
senescence (see chapter 2.2).  
2.1.4 The double-strand break repair pathways 
Among the different types of DNA damage, DSBs are considered the most deleterious, 
because they can be responsible for cell death or chromosomal translocations leading to 
cancer. There are two major pathways for the repair of DSBs, the homologous 
recombination (HR) and the non-homologous end joining (NHEJ) (Chapman et al., 2012). 
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HR is an error-free mechanism as it uses a homologous chromosome as template for repair, 
so it can occur during S and G2 phases of the cell cycle (Karpenshif and Bernstein, 2012). 
An early event in HR is the resection of the DSB in the 5'-to-3' direction. The MRN 
complex has a DNA-binding activity, an endonuclease and 3’-5’ exonuclease activity. It 
functions together with additional exo- and endo-nucleases such as BLM and EXO1, to 
resect DSBs and create 3’- ended single-stranded DNA that is required to initiate DNA 
strand invasion. RPA then coats the growing 3’ overhang. The RAD51 recombinase is then 
loaded onto the ssDNA, displacing RPA, and catalyses strand exchange. The 3’ ssDNA 
invades the intact homologous duplex DNA with the 3’ OH group, using the intact 
homologous duplex as a template to repair the DSB (Chapman et al., 2012). Subsequently, 
a DNA polymerase extends the 3' terminus of the damaged molecule, DNA ligation takes 
place and RecQ helicases, such as the BLM and WRN proteins resolve Holliday junctions 
to obtain two intact DNA molecules.  
NHEJ is active throughout the entire cell cycle, but is the only mode of repair during G0, 
G1 and early S phase when sister chromatids are unavailable (Lieber, 2010). Although 
NHEJ is highly efficient, its very simple mechanism of basic re-ligation, without 
proofreading, makes it prone to mutations. DNA ends are recognized by KU70/80 
heterodimeric complex, followed by recruitment of DNA-PK catalytic subunit (DNA-
PKcs) that phosphorylates itself and other targets among which the nuclease Artemis. 
Members of POLX family synthetize DNA and finally DNA ligase IV in association with 
its binding partners, XRCC4 and XLF, ligates the DNA ends.  
In the absence of protein machinery involved in classical NHEJ (c-NHEJ), another 
pathway can contribute to DSB repair, the alternative NHEJ (a-NHEJ), also known as 
backup NHEJ (b-NHEJ) or microhomology-mediated end joining (MMEJ), because it 
exploits microhomology regions during joining (McVey and Lee, 2008; Nussenzweig and 
Nussenzweig, 2007; Wang et al., 2003). The mechanisms of a-NHEJ are not fully 
understood yet, however DNA ligase 3 and XRCC1 seem to play a major role. 
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KU70/80 heterodimer plays a major role in the repair pathway choice, promoting c-NHEJ, 
likely by inhibiting the access of the DNA end to RAD52 or PARP-1, components of HR 
and a-NHEJ pathways respectively (Fattah et al., 2010). RIF1 is also essential for the 
repair pathway choice; it is recruited by phosphorylated 53BP1 and promotes NHEJ at 
DSBs in G1 phase as well as at uncapped telomeres, while in S/G2 CtIP and BRCA1 
displace 53BP1/RIF1 complex promoting HR (Chapman et al., 2013; Di Virgilio et al., 
2013; Escribano-Diaz et al., 2013; Zimmermann et al., 2013). 
2.1.5 Defects in DNA repair and checkpoint processes 
The importance of the DDR signalling and DNA repair are evident, considering the variety 
of diseases linked to mutations or defects in these pathways. For example, inherited 
mutations in the ATM gene results in the syndrome ataxia-telangiectasia (AT), a rare 
human disease characterized by ataxia (dysfunction in movement coordination by the 
nervous system), telangiectasia (dilated blood vessels), immune defects, increased 
sensitivity towards IR, and cancer predisposition (Shiloh and Ziv, 2013). The Nijmegen 
breakage syndrome (NBS) is caused by mutations in the NBS1 gene, and it is characterized 
by symptoms similar to AT (Digweed and Sperling, 2004). In some patients with AT-like 
disorders, mutations in the MRE11 gene were identified (Stewart et al., 1999). Disruption 
of both alleles of ATR causes embryonic lethality in mice, however hypomorphic 
mutations in ATR cause the Seckel syndrome in humans (O'Driscoll et al., 2003). These 
patients show growth retardation, dwarfism, microencephaly and mental retardation. A 
human syndrome, called RIDDLE (Radiosensitivity, Immunodeficiency, Dysmorphic 
features and LEarning difficulties) is due to the mutation of ubiquitin ligase RNF168 that 
leads to an impaired recruitment of 53BP1 and BRCA1 to sites of DNA DSBs (Stewart et 
al., 2009; Stewart et al., 2007). Haploinsufficiency for H2AX results in detectable genomic 
instability and enhanced tumour susceptibility in the absence of p53 (Celeste et al., 2003). 
Homozygous loss of CHK1 is lethal, but CHK1 heterozygosity modestly enhances the 
tumorigenic phenotype of WNT1 transgenic mice (Liu et al., 2000). Lack of CHK2 
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enhances skin tumorigenesis induced by carcinogen exposure (Hirao et al., 2002) and 
increases tumour susceptibility in mouse models, in combination with mutations in other 
genes like BRCA1, NBS1 and MRE11 (Cao et al., 2006; McPherson et al., 2004; Stracker 
et al., 2008). The inheritance of a single mutated allele of either BRCA1 or BRCA2 
markedly increases the incidence of breast and ovarian cancers in women (O'Donovan and 
Livingston, 2010).  
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2.2 Cellular senescence 
2.2.1 General features of cellular senescence 
Cellular senescence was first discovered by Hayflick and Moorhead in 1961, when they 
observed that human lung foetal fibroblasts in culture do not proliferate indefinitely, but 
can undergo a limited number of cell divisions, and eventually stop dividing, reaching the 
so-called Hayflick limit (Hayflick and Moorhead, 1961). Normal and primary cells in 
culture are in fact mortal and undergo cellular senescence in response to different types of 
stresses, like dysfunctional telomeres, DNA damage, and oncogene activation.  
Cellular senescence is defined as a permanent loss of proliferative capacity, despite 
viability and metabolic activity. It is indeed distinct from quiescence, because it cannot be 
reverted by appropriate mitogenic stimuli and changes in the culturing conditions 
(Kuilman et al., 2010). Although there are no exclusive markers for senescent cells, some 
features are commonly used to identify them.   
- Growth arrest. The lack of DNA replication is a typical characteristic of senescence 
establishment, although it does not distinguish senescent cells from quiescent or 
differentiated post-mitotic cells. It can be detected by the incorporation of 5-
bromodeoxyuridine (BrdU), or by expression levels of proliferation markers, such as 
PCNA and Ki-67.  
- Morphology. Senescent cells can be identified by an enlarged and flattened 
morphology with abnormally large cytoplasm.  
- Senescence-associated-β-galactosidase (SA-β-gal). Lysosomal β-galactosidase, 
encoded by GLB1 gene, is normally active at acidic pH 4.5. Its expression level 
increases during senescence due to an expansion in the lysosomal compartment, so its 
activity can be detected also in suboptimal conditions, at pH 6 (Dimri et al., 1995).  
- Senescence-associated DNA-damage foci (SDFs). The DDR activation can be detected 
in the form of SDFs, which contain proteins that are associated with the DDR, like 
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γH2AX, 53BP1, ATM pS1981 and MDC1 (d'Adda di Fagagna et al., 2003; Di Micco 
et al., 2006; Herbig et al., 2004; Takai et al., 2003). These foci differ from the ones 
found in non-senescent cells because they are usually larger and long-lived. DDR 
plays an essential role both in senescence initiation and maintenance. In senescent 
cells the DDR is actively maintained and is necessary for the senescence establishment 
(d'Adda di Fagagna et al., 2003; Herbig et al., 2004; Sedelnikova et al., 2004; von 
Zglinicki et al., 2005). Indeed transient inactivation of ATM, alone or together with 
ATR, and combined CHK1 and CHK2 inactivation, lead to escape from senescence 
and re-entry into the S-phase of the cell cycle. In contrast with these observations, 
some reports describe that deep senescent cells eventually lose  DDR foci (Bakkenist 
et al., 2004; Chen and Ozanne, 2006). This is against the hypothesis that DDR fuels 
and maintains cellular senescence. However, I will show that this can be at least 
partially explained by the cell type-specific response to stress (see chapter 4.1.3). 
- Activation of tumour suppressor networks. The senescence growth arrest is established 
and maintained by p53 or p16-RB tumour suppressor pathways (Kuilman et al., 2010). 
Different cell types or species can activate one pathway or both, also in response to 
different stimuli. For example, IR and telomere dysfunction induce senescence 
primarily through the p53 and p21 pathway in fibroblasts (Brown et al., 1997). In 
other cell types, like melanocytes, senescence is mediated by p16-RB pathway 
(Haferkamp et al., 2009). There are also species-specific differences: for example, 
experimental uncapping of telomeres primarily engages the p53 pathway in mouse 
cells but both the p53 and p16-RB pathways in human cells (Smogorzewska and de 
Lange, 2002). p16 and p21 can both keep pRB in an active, hypophosphorylated form, 
thereby preventing E2F from transcribing genes that are needed for proliferation 
(Sherr and McCormick, 2002). 
- Senescent-associated secretory phenotype (SASP). The senescent status is often 
associated with a secretome that includes different cytokines and chemokines (Coppe 
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et al., 2008; Rodier et al., 2009). These factors can trigger modifications of the 
extracellular matrix or mediate local inflammation. They can bind receptors on the 
same cell that secreted them (autocrine effect) or on the surrounding cells (paracrine 
effect), fuelling the senescence state (Acosta et al., 2013). 
- Senescence-associated heterochromatin foci (SAHFs). In some senescent cells, the 
chromatin is reorganized into discrete foci (Narita et al., 2003). SAHFs are detected by 
the preferential binding of DNA dyes, such as 4',6-diamidino-2-phenylindole (DAPI), 
and the presence of heterochromatin-associated histone modifications like H3K9 
methylation, and proteins, like heterochromatin protein-1 (HP1). 
2.2.2 Replicative senescence 
Senescence as a result of proliferative exhaustion in optimal culturing conditions is known 
as replicative senescence. Telomeres are the end of linear chromosomes, which lose 50–
200 base pairs during each S phase (see chapter 2.3). Progressive telomere shortening 
eventually causes chromosome ends to be recognized as DNA breaks, to activate a 
consequent DDR and to enforce senescence. Thus cell proliferation inevitably arrest 
because of an intrinsic “clock” that is sensitive to the number of cell divisions rather than 
the time in culture. The causative role of telomere shortening in replicative senescence 
establishment was proven by reactivation of telomerase that prevents senescence and 
allows unlimited cell proliferation in vitro (Blackburn, 2000; Bodnar et al., 1998). 
Importantly, senescence is not determined by the average telomere length within a cell but 
by the presence of a few telomeres sufficiently short to trigger the senescent signal 
(Hemann et al., 2001; Herbig et al., 2004).  
2.2.3 Stress-induced premature senescence 
The Stress-induced premature senescence (SIPS) is a response to an external stress coming 
from the cell environment (Toussaint et al., 2000). Repeated or acute non-lethal doses of 
these stresses are required to efficiently induce accumulation of stress-induced senescent 
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cells. Cells undergoing SIPS share many cellular and molecular features with replicative 
senescent cells. Different types of stresses can induce the SIPS. 
- Culture shock-induced senescence. An important example of SIPS comes from the 
biological behaviour of primary mouse embryonic fibroblasts (MEFs). Explanted 
MEFs stop dividing after only 15-30 cell divisions when placed in culture. Since 
telomeres are quite long in laboratory mouse strains, the proliferative block occurs 
well before detectable critical telomere shortening. Moreover, many somatic mouse 
tissues and cultured cells express telomerase activity (Prowse and Greider, 1995). 
Non-physiologic conditions including disruption of cell-cell contacts, lack of 
heterotypic interactions between different cell types, the medium-to-cell ratio, 
persistent RAS activation by mitogens, absence of appropriate survival factors, 
hyperoxia and plating on plastic are likely to induce stress responses (Sherr and 
DePinho, 2000). Among these factors, oxygen sensitivity is one of the major 
determinants of SIPS. MEFs do not senesce in physiological (3%) oxygen levels, but 
do so at 20% oxygen (Parrinello et al., 2003). Serum is also a recognized senescence-
inducing factor. In fact, MEFs, glial and oligodendrocytes precursors have been shown 
to proliferate without apparent limits if grown in synthetic media without serum 
(Mathon et al., 2001; Tang et al., 2001; Woo and Poon, 2004). Moreover mitogenic 
stimuli have been shown to increase activation of DNA damage responses in senescent 
cells, likely to prevent senescent cells from entering the cell cycle (Satyanarayana et 
al., 2004). 
- UV and IR-induced senescence. UV light is composed of UVA (320-400 nm), UVB 
(280-320 nm), and UVC (200-280 nm). UVB, in particular, is the most hazardous 
environmental carcinogen known in regard to human health. UVB irradiation is 
known to provoke oxidative stress through the generation of ROS that could be the 
cause of UV-induced SIPS (de Magalhaes et al., 2002). ROS removal by the use of 
free radical scavengers reduces the harmful effects of UVB irradiation resulting in a 
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significant delay in SIPS establishment (Ho et al., 2005). IRs are also inducers of 
SIPS. IR-treatment creates DSBs resulting in the activation of ATM-p53-p21 pathway 
within few hours from treatment. However, SIPS is not associated with telomeric 
shortening and IR does not appear to accelerate telomere erosion. Moreover 
expression of hTERT in different types of normal diploid cells undergoing SIPS by 
IR, as well as UV treatment and hydrogen peroxide exposure, did not prevent 
senescence induction. These data indicate that DNA lesions can induce senescence 
through a mechanism that is independent from telomere shortening (Gorbunova et al., 
2002). 
- DNA damaging drug-induced senescence. Many chemotherapy agents used to treat 
cancer, can induce SIPS, without affecting telomere length (Schmitt, 2003). Some 
examples are the DNA-intercalating doxorubicin, the topoisomerase I inhibitor 
camptothecin, the topoisomerase II inhibitor adriamycin, the cross-linking agent 
cisplatin, the anti-metabolite cytarabin. Moreover, chronic exposure to low 
concentrations of hydroxyurea, aphidicolin, or etoposide can also induce replication 
stress leading to irreversible cell cycle arrest after several population doublings and to 
checkpoint activation. Indeed, since replication stress stalls replication forks and some 
of the stalled forks can collapse, this leads to the generation of DSBs and the 
activation of the ATR/CHK1 pathway (Marusyk et al., 2007).  
2.2.4 Oncogene-induced senescence 
Oncogenes are mutant versions of normal genes that have the potential to transform cells 
in conjunction with additional mutations. Normal cells respond to many oncogenes by 
undergoing senescence. A common feature of the expression of various oncogenes in vivo 
and in vitro is the generation of a biphasic response: cells undergo an initial burst of 
cellular hyperproliferation followed by senescence establishment (Di Micco et al., 2006; 
Di Micco et al., 2007). Cellular senescence indeed prevents the expansion of a pool of cells 
bearing an activated oncogene and thus restrains the formation of a potential tumour. 
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Oncogene-induced senescence (OIS) was first described in cells expressing the 
constitutively activated and therefore oncogenic form of RAS, a cytoplasmic transducer of 
extracellular growth stimuli (Serrano et al., 1997). In the same way, activation or increased 
expression of other components of the RAS pathway, such as RAC1, RAF, MOS, MEK or 
the loss of the inhibitor of the RAS pathway PTEN can induce cellular senescence; a list of 
senescence-inducing gene is reviewed in (Evan and d'Adda di Fagagna, 2009). OIS and 
replicative senescence have some common features. For example, oncogenic RAS induces 
p16 and the formation of SAHFs (Kreiling et al., 2011; Narita et al., 2003; Zhang et al., 
2005). In addition, in cells expressing oncogenes, DDR markers localize at DNA-
replication sites, aberrant amounts of single-stranded DNA are generated and replicative 
fork progression is discontinuous and prone to pausing and/or collapse (Bartkova et al., 
2006). Moreover, RAS activation induces re-replication, an event known to cause DNA 
damage and DDR activation and to increase the number of actives origins (Di Micco et al., 
2006). Similarly, MYC boosts the number of active DNA replication origins; its 
deregulation induces DNA damage in a DNA replication-dependent manner (Dominguez-
Sola et al., 2007). Therefore, all these observations suggest that oncogene-induced altered 
DNA replication is an important contributor to oncogene genotoxicity and senescence 
establishment.  
2.2.5 Cellular senescence and ageing  
Increasing evidence suggests the presence of senescent cells in vivo, and their contribution 
to organismal ageing. Telomere shortening has an impact on tissue ageing in various 
tissues (Tumpel and Rudolph, 2012), and senescent cells have been found in human skin 
fibroblasts (Dimri et al., 1995), in baboons skin fibroblasts (Herbig et al., 2006) and in 
mouse stem and somatic cells (Nijnik et al., 2007; Rossi et al., 2007; Sedelnikova et al., 
2004; Wang et al., 2009). Different markers of senescence are used to identify senescent 
cells in vivo, among which the SA-β-gal activity, DDR activation, increased p16 
expression, heterochromatin formation. Senescent cells can contribute to organismal 
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ageing by up-regulating genes that encode extracellular-matrix-degrading enzymes, 
inflammatory cytokines and growth factors, which stimulate chronic tissue remodelling 
and local inflammation, compromising tissue structure and function (Nelson et al., 2012). 
Notably, cells that express senescence markers are also found at sites of age-related 
pathologies, such as osteoarthritis and atherosclerosis (Chang and Harley, 1995; Price et 
al., 2002; Vasile et al., 2001). The causative effect of senescence on ageing is supported by 
different observations. p16 expression increases with age in the stem and progenitor cells 
of the mouse brain, bone marrow and pancreas, where it suppresses stem-cell proliferation 
and tissue regeneration. Consistently, the age-related decline can be prevented by the lack 
of p16 expression (Janzen et al., 2006; Krishnamurthy et al., 2006; Molofsky et al., 2006). 
Similarly, a genetically engineered mouse model in which p16-expressing cells are 
specifically cleared, show a delay in age-related pathologies, an attenuation of already 
established disorders, and increased lifespan (Baker et al., 2011).  
Dysfunctional telomeres have been found in senescent cells in vivo in primates (Herbig et 
al., 2006; Jeyapalan et al., 2007), and loss of telomerase function in mice causes 
senescence and physiological impairment of many tissues (Ferron et al., 2004; Rudolph et 
al., 1999; Sahin and Depinho, 2010; Satyanarayana et al., 2004). Consistent with a 
causative role of replicative senescence in organism ageing, deletion of p21 in telomerase-
deficient mice with dysfunctional telomeres improves hematolymphopoiesis, rescues the 
maintenance of intestinal epithelia and prolongs the lifespan (Choudhury et al., 2007). 
Moreover elongation of telomeres by reactivation of telomerase is sufficient to eliminate 
the degenerative phenotypes in multiple organs observed in telomerase knock out mice 
(Jaskelioff et al., 2011). 
2.2.6 Cellular senescence and cancer 
Cellular senescence is considered a potent tumour suppressive mechanism. Indeed OIS 
have been demonstrated to prevent cancer development in vivo both in humans and in 
mouse models (Dankort et al., 2007; Di Micco et al., 2006; Grandori et al., 2003; Lazzerini 
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Denchi et al., 2005; Michaloglou et al., 2005). Senescent cells are associated with benign 
dysplastic or pre-neoplastic lesions but not with malignant tumours suggesting that tumoral 
cells escaped the senescence barrier triggered by hyperproliferation (Collado and Serrano, 
2010; Suram et al., 2012). They are also found in normal and tumour tissues following 
DNA-damaging chemotherapy (Collado and Serrano, 2010). 
Also replicative senescence seems to play an important role in preventing cancer onset. 
Indeed cancer cells need a system to overcome telomere attrition and proliferate 
indefinitely. This is usually achieved by most human tumours through the expression of 
high levels of telomerase, that in human somatic tissues is absent (Meyerson, 2000). It has 
been shown that telomerase expression is necessary for full transformation of oncogene-
expressing human cells (Hahn et al., 1999). This can be in part due to the ability of 
telomerase to prevent or suppress DDR activation at telomeres upon telomeric shortening 
and oncogene-induced replication stress (Gunes and Rudolph, 2013). Nevertheless, a 
transient telomere dysfunction promotes tumour initiation by generating chromosomal 
instability and polyploidy (Begus-Nahrmann et al., 2012; Davoli and de Lange, 2012; 
Rudolph et al., 1999). A minor fraction of human cancers (10–20%) are telomerase-
negative and activate HR-based alternative lengthening of telomere (ALT) (Cesare and 
Reddel, 2010). ALT is also responsible for tumour relapse upon telomerase inhibition in 
mouse models (Hu et al., 2012).  
Finally the inability to establish cellular senescence in mouse models deficient for p16 
leads to increased cancer incidence (Janzen et al., 2006; Krishnamurthy et al., 2006; 
Molofsky et al., 2006).  
All these results indicate that cellular senescence suppresses the development of cancer. 
However, it has been suggested that factors secreted by senescent cells can facilitate the 
development of cancer by promoting cell proliferation, mobility and differentiation and by 
modulating the immune response (Coppe et al., 2010). Thus cellular senescence has a dual 
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role in preventing uncontrolled proliferation leading to cancer, but also favouring tumour 
growth of surrounding cells. 
2.3 Telomeres and telomere-binding proteins 
2.3.1 Structure of the telomeres 
Telomeres are nucleoprotein structures at the end of the linear chromosomes (Fig 2). They 
are made of three main components: long stretches of DNA tandem repeats (TTAGGG in 
vertebrates), telomere-associated proteins and non-coding RNA. The length of human 
telomeres is typically 9-15 Kb, whereas laboratory mouse strains chromosomes have 
longer telomeres, ranging from 10 to 60 Kb. Telomeres terminate in a 3' protruding single-
stranded G-rich overhang, typically 50-300 nucleotides long (O'Sullivan and Karlseder, 
2010). The overhang is generated through 5’-3’ resection by Apollo and Exo1 nucleases 
(Wu et al., 2012) and is essential for TRF2-mediated invasion of preceding double-
stranded DNA region to form a high-order structure known as t-loop (Griffith et al., 1999; 
Stansel et al., 2001). The G-rich end can also fold up into four-stranded G-quadruplex 
structure, an unusual DNA conformation based on a guanine quartet (Lipps and Rhodes, 
2009). 
Telomeres and subtelomeres are enriched for heterochromatic markers, such as H3K9me3, 
H4K20me3 and HP1. In addition, subtelomeric DNA is methylated. Both histone and 
DNA methylations act as negative regulators of telomere length, by inhibiting telomerase 
activity (Schoeftner and Blasco, 2009). The heterochromatin maintenance is regulated by 
the miR-290 family, which controls a subset of DNA methyltransferases; indeed mice 
deficient for Dicer1 show a decreased DNA methylation and increased telomere 
recombination and elongation (Benetti et al., 2008a). 
 
 38 
 
Adapted from (O'Sullivan and Karlseder, 2010) 
Figure 2. Structure of the human telomeres.  
Human telomeres are nucleoprotein complexes consisting of kilobases of TTAGGG repeats, with a 3’ G-rich 
overhang, an RNA component called TERRA and the shelterin proteins TRF1, TRF2, RAP1, TIN2, TPP1 
and POT1. These factors help the formation of a protective structure at chromosome ends, the t-loop. 
Activation of ATM is inhibited by TRF2, while ATR is inhibited by POT1. Telomerase is probably inhibited 
by the shelterin proteins.  
 
 
Results by Marzia 
Fumagalli 
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2.3.2 Telomere-binding proteins 
Telomeres are associated to a protein complex named shelterin, consisting of six 
components (de Lange, 2005): TRF1 and TRF2 (telomeric-repeat-binding factor 1 and 2), 
POT1 (protection of telomeres 1), RAP1 (also known as TERF2IP, telomeric repeat 
binding factor 2 interacting protein), TIN2 (TRF1-interacting nuclear factor 2) and TPP1 
(POT1 and TIN2 organizing protein). 
TRF1 and TRF2 directly associate as homodimers with the double-stranded telomeric 
DNA, through their MYB domain (Broccoli et al., 1997). TRF1 has been proposed to 
allow efficient replication of telomeres, preventing fork stalling (Martinez et al., 2009; 
Sfeir et al., 2009) and to act as a negative regulator of the telomere length, probably by 
controlling the access of telomerase (Ancelin et al., 2002; Munoz et al., 2009; van Steensel 
and de Lange, 1997). TRF2 maintains the t-loop structure and is mainly implicated in 
chromosome end protection, by preventing end-to-end fusions (Griffith et al., 1999; 
Stansel et al., 2001; van Steensel et al., 1998); it is also involved in the telomeric 
heterochromatin maintenance (Benetti et al., 2008b). POT1 coats the single-stranded 
overhang using two oligonucleotide/oligosaccharide binding folds and positively regulates 
telomere length in a telomerase-dependent manner (Baumann and Cech, 2001; Colgin et 
al., 2003). RAP1 binds to TRF2 and is involved in telomere-length regulation, telomere 
stability, and silencing of subtelomeric genes (Hardy et al., 1992; Lustig et al., 1990; 
Martinez et al., 2010). TIN2 connects TRF1 to TRF2 and can form a bridge with POT1 via 
TPP1, contributing to the stabilization of shelterin at telomeres (Ye and de Lange, 2004; 
Ye et al., 2004a; Ye et al., 2004b).  
The CST complex, composed by Cdc13, Stn1 and Ten1, and first discovered in budding 
yeast, binds directly the 3’ overhang of telomeres and has structural similarity to the RPA 
heterotrimer (Giraud-Panis et al., 2010). Yeast Cdc13 protects the C-rich strand from 
degradation, interacts with the telomerase RNA component Est1, promoting telomere 
elongation, and with Pol1, preventing the formation of long C-strand (Qi and Zakian, 
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2000). Stn1 competes with telomerase for the binding to Cdc13, down-regulating 
telomerase activity (Chandra et al., 2001). Finally Ten1 enhances Cdc13 binding affinity to 
DNA (Qian et al., 2009). Stn1 and Ten1-related proteins have been found in higher 
eukaryotes, including humans, while the CTC1 protein is thought to have functions similar 
to Cdc13 (Miyake et al., 2009). The human CST complex binds only partially to the 
telomeres, and it has a role in the telomere protection, G-overhang control and in 
regulating Polα-Primase activity (Giraud-Panis et al., 2010). 
Recently, a mass spectrometry-based screening identified HOT1 as a novel telomere-
associated protein that directly binds to telomeric DNA (Kappei et al., 2013). Its 
recruitment is restricted to the actively elongated telomeres, where it promotes telomerase 
association.  
2.3.3 Telomeric transcripts 
Despite their heterochromatic structure, telomeres from yeast to humans are transcribed 
into telomeric repeat-containing RNA (TERRA) (Azzalin et al., 2007; Schoeftner and 
Blasco, 2008). TERRA are transcribed by RNA Polymerase II starting from promoters 
located in the subtelomeric regions through the telomeric repeats. They are polyadenilated, 
contain the G-rich telomeric sequence and are heterogeneous in size, ranging from around 
0.1 to 9 Kb. Their expression levels are positively regulated by TRF1, which interacts with 
RNA Polymerase II, while heterochromatin is repressing their transcription (Schoeftner 
and Blasco, 2008). TERRA expression level is also regulated in a cell cycle dependent 
manner in human cells, reaching the maximum in G1 phase of the cell cycle and 
progressively decline in the S phase reaching their lowest levels in late S/G2 phase (Porro 
et al., 2010). The physiological functions of TERRA have not been completely elucidated 
yet, but some reports suggest that they can negatively regulate telomere length. In vitro 
experiments showed that TERRA block telomerase activity possibly by RNA duplex 
formation with the template region of Terc (Schoeftner and Blasco, 2008). However, in 
budding yeast, it has recently been shown that TERRA are able to induce telomerase 
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nucleation, favouring telomere elongation (Cusanelli et al., 2013). Consistently, long 
telomeres can inhibit TERRA expression by promoting heterochromatin formation 
(Arnoult et al., 2012). TERRA are also able to inhibit POT1 displacement by RAP1 during 
the G1 phase, allowing the protection of the telomeres (Flynn et al., 2011). However, in S 
phase, TERRA levels decrease, so the switch between POT1 and RAP1 can take place, in 
order to complete DNA synthesis. Finally, when TERRA accumulate again in G2, they 
promote again POT1 binding to telomeric DNA.  
2.3.4 Mechanisms of telomere length maintenance 
At each cell division telomere length is reduced due to the inability of the DNA replication 
machinery to copy the most distal telomeric sequences of the lagging-strand, and to the 
exonucleolytic processing needed to generate the overhang (Harley et al., 1990). This 
phenomenon is known as the “end replication problem” (Watson, 1972) and in most cases 
is solved by elongation of telomeric DNA by the telomerase enzyme. The telomerase 
complex consists of the reverse transcriptase catalytic subunit (TERT), the RNA 
component (TERC) used as a template to elongate the G-rich telomeric DNA strand, 
dyskerin that helps the assembly of the complex and TCAB1, involved in the localization 
of telomerase to the Cajal Bodies (Cohen et al., 2007; Greider and Blackburn, 1985; 
Mitchell et al., 1999; Venteicher et al., 2009). In humans, telomerase activity is restricted 
to the embryogenesis, while TERT expression is switched off in most somatic cells, with 
the exception of activated lymphocytes, adult stem cells and germ line (Wright et al., 
1996). Telomerase function has been intensively studied in yeast, where it has been shown 
that telomere elongation is restricted to the S phase, when telomeres are replicated 
(Marcand et al., 2000). Furthermore, telomerase exhibits an increasing preference for 
telomeres as their length decline, suggesting that telomeres switch between non-extendible 
and extendible states. The repeat addition processivity varies between a few to >100 
nucleotides, and is enhanced at extremely short telomeres, allowing cells to rapidly 
elongate them (Teixeira et al., 2004). Consistently, late generation heterozygous mice for 
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telomerase gene, have short telomeres, comparable with late generation Tert knock out 
mice, but do not display the associated phenotype, suggesting that a minimal amount of 
telomerase is sufficient to elongate the critically short telomeres (Chiang et al., 2010). 
Mutation and impaired activity of telomerase have been associated with ageing-associated 
phenotypes and many different types of human tumours (Bernardes de Jesus and Blasco, 
2013). 
Approximately 10–20% of human cancers maintain their telomeres by ALT (Cesare and 
Reddel, 2010). It has been reported that the telomeric 3′ overhangs exploit the HR 
machinery to invade other telomeric DNA, and use it as a template for DNA replication. 
Telomeres in ALT cells are heterogeneous in length; some of them are very short, but they 
can reach up to 100 Kb. Extrachromosomal telomeric DNA can be found in t-circle of 1–
60 Kb. 
2.3.5 Telomeres and the DDR 
Despite their structural similarities, telomeres are not recognised as DSBs by the cellular 
DDR machinery. The shelterin complex is the main factor involved in this process, since 
the activation of the DDR apical kinases ATM and ATR is inhibited by TRF2 and POT1, 
respectively (Lazzerini Denchi and de Lange, 2007). In the absence of either of these 
proteins, DDR foci, containing the same proteins found at DSBs, are detectable at the 
telomeres. In in vitro experiments, TRF2 has been shown to inhibit NHEJ (Bae and 
Baumann, 2007; Bombarde et al., 2010). Consistently, TRF2 knock out in mouse cells 
leads to dramatic chromosomal fusions (Celli and de Lange, 2005; van Steensel et al., 
1998), which can be mostly prevented by Ligase 4 and 53BP1 depletion, indicating that the 
NHEJ is the fundamental repair pathway acting at uncapped telomeres in vivo (Sfeir and de 
Lange, 2012). KU70/80 heterodimer is a component of the NHEJ, nevertheless it is found 
at the telomeres (d'Adda di Fagagna et al., 2001); its main function is to inhibit both a-
NHEJ and HR events (Indiviglio and Bertuch, 2009). Also some shelterin proteins are able 
to repress the HR pathway; RAP1-free telomeres undergo recombination, even in the 
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absence of DDR activation (Sfeir and de Lange, 2012), while POT1 can suppress HR 
together with resection at telomeres (Palm et al., 2009).  
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2.4 The role of non-coding RNAs in DDR  
2.4.1 Non-coding RNA 
Non-coding RNAs (ncRNAs) are defined as RNA species that do not have protein coding 
potential. A variety of ncRNA exist with many different functions. They include ribosomal 
RNAs (rRNAs), transfer RNAs (tRNAs), small nuclear RNAs (snRNAs), small nucleolar 
RNAs (snoRNAs), long non-coding RNAs (lncRNAs) and small ncRNAs that are short 
(<200 nt), and can be further divided into microRNAs (miRNAs), small interfering RNAs 
(siRNAs) and piwi interacting RNAs (piRNAs). In addition to the well-defined classes of 
ncRNA, increasing amount of data have suggested that non-coding transcripts are 
generated from the vast part of the genome that was previously thought to be 
transcriptionally silent, a phenomenon known as pervasive transcription (Birney et al., 
2007). Although the function of these transcripts is still unknown, it is likely that they play 
an active role in different biological processes.  
2.4.2 DROSHA and DICER functions in ncRNA biogenesis 
DROSHA and DICER are two important players of the RNA interference (RNAi) 
machinery (Fig. 3). DROSHA is a nuclear RNase III enzyme responsible for the initial 
processing of the miRNAs. It cleaves the primary miRNA (pri-miRNA), a transcript 
generated from the endogenous miRNA genes, that is generally longer than 1000 nt, and 
contains single or clustered double-stranded hairpins, with single-stranded 5′- and 3′- 
overhangs and 10 nt distal loops (Saini et al., 2007). The resulting precursor miRNA (pre-
miRNA) associates with EXPORTIN-5 to be translocated to the cytoplasm (Lund and 
Dahlberg, 2006).  
DICER is an endoribonuclease containing a helicase and an RNase III activity. It can cut 
pre-miRNAs as well as exogenous siRNAs into a duplex of 21-25 nt, with a 2 nt overhang 
at each 3′ terminus and a phosphate group at each recessed 5′ terminus (Schwarz et al., 
2003). The resulting processed dsRNA is loaded into the RISC complex.  
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Adapted from (Jinek and Doudna, 2009) 
Figure 3. Small ncRNA biogenesis.  
miRNAs (left) are transcribed by endogenous genes in pri-miRNAs, which are initially processed by 
DROSHA/DGCR8 complex in the nucleus. In the cytoplasm, DICER cleaves the hairpin structure, 
generating the pre-miRNA, loaded on the RISC complex. Argonaute protein, bound to the guide strand, 
mediates the binding to the target mRNA, promoting translational repression and deanylation. dsRNA 
molecules resulting from viral RNA, convergent transcription, self-annealing transcripts or experimental 
transfection are processed by the siRNA pathway (right). DICER generates the siRNA duplex and AGO2 
cleaves the target mRNA. 
 
 
miRNA siRNA 
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One of its components, Argonaute, binds the guide strand and mediates the cleavage of the 
complementary messenger RNA (mRNA) if the pairing is perfect. In alternative, it induces 
a translational repression followed by deadenylation and degradation. The Argonaute-
binding protein GW182 is a key mediator in recruiting additional components that mediate 
translational repression and mRNA decay (Eulalio et al., 2008). 
2.4.3 Interplay between ncRNAs and DDR 
A link between ncRNA and DDR is recently emerging. DDR factors can indeed directly 
regulate the biogenesis of miRNAs by controlling their maturation: for instance ATM 
phosphorylates a panel of DROSHA interactors, including KSRP (Bensimon et al., 2010; 
Zhang et al., 2011), while BRCA1 interacts with DROSHA (Kawai and Amano, 2012). 
Some miRNAs target DDR genes such as ATM, DNA-PKcs, BRCA1, H2AX and RAD51 
mRNAs (Hu et al., 2010; Lal et al., 2009; Moskwa et al., 2011; Wang et al., 2012; Yan et 
al., 2010).  
However, recent evidence suggests a direct involvement of non-canonical small ncRNAs 
in the modulation of DDR and DNA repair events. In mammalian cells damaged by IR, 
enzymatic DNA cleavage or oncogene-induced replicative stress, DROSHA or DICER 
inactivation reduces the formation of DDR foci containing upstream signalling factors, 
such as the activated form of ATM, 53BP1 and MDC1, while γH2AX foci are not affected 
(Francia et al., 2012). The same effect is not observed upon down-regulation of GW 
proteins, downstream effectors of RNAi machinery, thus excluding a contribution of the 
canonical miRNAs biogenesis pathway. Many experimental data strongly indicate that 
DROSHA and DICER process a novel class of short RNAs (20-35 nt), generated at DSB 
site with the same sequence of the damaged locus. They are called DNA damage response 
RNAs (DDRNAs) and are necessary for the formation and maintenance of DDR foci 
(Francia et al., 2012). The recent finding that human DICER can shuttle between 
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cytoplasm and nucleus strongly suggests a local processing of DDRNAs at the DNA 
damage site (Doyle et al., 2013).  
Similarly, in Arabidopsis thaliana and in human cells, 21-24 nt long RNAs, named DSB-
induced RNAs (diRNAs), are involved in DNA repair by HR (Wei et al., 2012). They have 
the same sequence of the broken DNA, are transcribed by RNA Polymerase IV, and their 
biogenesis involves the components of the RNAi machinery Dicer-like proteins and Ago2. 
In Drosophila melanogaster, endogenous small interfering RNAs (endo-RNAs) are 
generated from a transfected linearized plasmid and they are able to silence transcription of 
homologous DNA sequences also in trans (Michalik et al., 2012). Finally in Neurospora 
crassa, small RNAs termed qiRNAs are transcribed from the rDNA locus in response to 
DNA damage (Lee et al., 2009). Although the mechanism of action of these RNAs is not 
clear yet, inactivation of proteins involved in their biogenesis increases the sensitivity to 
DNA damage. 
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3 Materials and Methods 
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3.1 Cell culture 
BJ cells (The American Type Culture Collection, ATCC), WI-38 cells (ATCC) and all BJ-
derived cell lines were grown in MEM supplemented with 10% foetal bovine serum, 1% 
L-glutamine, 1% non-essential amino acids, 1% sodium pyruvate. IMR-90 cells (ATCC) 
were grown in MEM supplemented with 15% foetal bovine serum, 1% L-glutamine, 1% 
non-essential amino acids, 1% sodium pyruvate. MRC-5, phoenix amphotropic (ATCC), 
HEK 293-T (ATCC) and Adeno-293 (Stratagene) cells were grown in DMEM, 
supplemented with 10% foetal bovine serum and 1% L-glutamine.  
BJ hTERT cells are a BJ-derived cell line that stably expresses human TERT gene 
(Fumagalli et al., 2012). BJ hTERT shp53 cells are a BJ hTERT-derived cell line that 
stably expresses an shRNA against p53 (Di Micco et al., 2006). BJ hTERT shGFP and 
shKAP-1 were obtained by retroviral infection of BJ hTERT cells with pRetroSuper 
shGFP or pRetroSuper shKAP-1 (Ziv et al., 2006) and selected with puromycin (1 µg/ml). 
BJ hTERT GFP and TRF2 cells were obtained by lentiviral infection of contact-inhibited 
BJ hTERT. BJ hTERT I-SceI, Telo, and Telo + I-SceI cells were obtained by 
electroporation of BJ hTERT cells, selected with G418 (400 µg/ml). To have 
homogeneous cell populations, cells were plated sparsely and individual clones were 
obtained by ring cloning.  
NIH 2/4 cells, a gift from Evi Soutoglou, IGBMC, Stransbourg, France (Soutoglou et al., 
2007), were grown in DMEM supplemented with 10% TET system approved foetal bovine 
serum, 1% L-glutamine, hygromicin (400 µg/ml); they are a NIH 3T3-derived cell line 
transfected with the lac–ISceI–tet plasmid. To induce Tet-YFP and Tet-YFP-TRF2 binding 
to the TetO array, doxycycline (1 µg/ml) was added to the culture medium for 3 hours. To 
induce RFP-I-SceI-GR translocation to the nucleus, 16 hours post transfection 
Triamcinolone Acetonide (Sigma-Aldrich, 10 pM) was added to culture medium. 3 hours 
after treatment, cells were fixed for immunostaining (I-SceI ON) or washed with PBS to 
inactivate the endonuclease and fixed for immunostaining 24 hours later (I-SceI OFF). 
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MEFs CRE-ER TRF2flox/flox cells, a gift from Eros Lazzerini Denchi, SCRIPPS, La Jolla, 
California, USA (Celli and de Lange, 2005), were grown in DMEM supplemented with 
10% foetal bovine serum and 1% glutamine; they are MEF-derived cell line in which both 
TRF2 alleles are loxP-flanked, and that stably expresses the CRE recombinase fused to the 
estrogen receptor (ER); for induction, cells were grown in the presence of 4-
hydroxytamoxifen (600 nM) for 48 hours, to allow CRE-ER to translocate into the nucleus 
and to generate the TRF2-/- cell line.  
T19 cells, a gift from Titia de Lange, Rockfeller University, New York, NY, USA (van 
Steensel et al., 1998), were grown in DMEM supplemented with 10% TET system 
approved foetal bovine serum, 1% L-glutamine, G418 (150 µg/ml) or hygromycin (90 
µg/ml), alternatively; they are a HT1080-derived clonal fibrosarcoma cell line with a Tet-
OFF system. They express the tetracyclin-controlled transactivator (tTA) and the dominant 
negative allele of TRF2 (TRF2ΔBΔM, containing aa 45-454 of the endogenous TRF2, 
lacking the basic and the myb domains) under the tetracycline-controlled promoter. Cells 
were grown in the presence of doxycycline (100 ng/ml), which impedes the binding of tTA 
to the promoter; expression of TRF2ΔBΔM was induced by removing doxycyclin from the 
medium, and telomere uncapping was established 7-8 days later.  
All cells were grown under standard tissue culture conditions, at 37°C, 5% CO2.  
To inhibit ATM kinase activity, the inhibitor KU55933 (Tocris bioscience), or its solvent 
DMSO, was used at 10 µM concentration in cell culture medium for 72 hours. To induce a 
global chromatin relaxation, valproic acid (VPA, Sigma-Aldrich), or its solvent PBS, was 
used for 16 hours at 1, 10 or 50 mM concentration in cell culture medium.  
3.2 Ionizing radiation 
IR at different doses was used to generate acute DNA damage exogenously. IR refers to 
highly energetic particles or waves that can detach (ionize) at least one electron from an 
atom or molecule. IR-induced lesions include base damage, SSBs, DSBs and DNA cross-
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links. DNA damage can be generated directly by IR or as secondary hits by free radical 
species. Examples of IR are energetic beta particles, neutrons, alpha particles, X- and 
Gamma Rays. X-rays are photons (electromagnetic radiations) emitted from electron 
orbits, such as when an excited orbital electron “falls” back to a lower energy orbit. The 
Gray (Gy) is the International System of Units of absorbed radiation dose, where 1 Gy is 
the absorption of 1 joule of radiation energy by 1 kilogram of matter. The radiation-
generating machine (Faxitron X-Ray Corporation) is based on a high-voltage X-rays 
generator tube. To induce IR-dependent cellular senescence, I irradiated cultured cells with 
20 Gy. Mice were irradiated with 8 Gy (total body IR) using GammaCell 200 and cobalt60 
as a source. 
3.3 Cell survival assay 
Cells were plated in 6 multi-well plates, grown until confluency and irradiated or not with 
the appropriate dose of IR. At each time point cells were washed to remove culture 
medium, collected by trypsinization and counted in triplicate using a Burker chamber. 
3.4 Retroviral infection 
Retroviruses are single-stranded RNA viruses. They express a reverse transcriptase to 
retro-transcribe genomic RNA into DNA, which is then inserted into the genome at a 
random position by the viral integrase enzyme. The integrated vector is called provirus and 
it is transmitted to the progeny through cell divisions. Retroviruses used in cellular biology 
are replication-defective, thus they cannot produce infective particles. For cells that are not 
easy to transfect, like human fibroblasts, retroviral infection is an efficient way to express 
exogenous genes; nevertheless the primary drawback to the use of retroviruses is the 
requirement for cells to be actively dividing for transduction. Phoenix is a second-
generation retrovirus producer cell line, based on the HEK 293T cell line that produces 
gag, pol and envelope proteins. The retroviral expression vectors provide the viral 
packaging signal (Ψ), the gene of interest under LTR promoter and an antibiotic resistance 
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marker. 48 hours before the transfection, packaging cells were plated at 1.8 million cells 
per 10 cm dish in cell growth medium. Phoenix amphotropic packaging cells were 
transfected by the calcium phosphate method. Calcium phosphate transfection is based on 
the formation of a precipitate containing calcium phosphate and DNA, which adheres to 
the cell surface and is internalized by endocytic process. Chloroquine, added to the 
medium at a final concentration of 40 µM for not more than 12 hours, increases retroviral 
titer by approximately two fold, by inhibiting lysosomal DNases by neutralizing vescicles 
pH. The precipitate is prepared by slowly mixing a HEPES-buffered saline solution 
containing sodium phosphate with a solution containing calcium chloride and high quality 
DNA (10 µg for each plate of phoenix cells). The HBS/DNA/CaCl2 solution was added to 
the cells within 1-2 minutes of preparation. The day after the transfection the growth 
medium was replaced with 5 ml of fresh medium to concentrate viral particles in the 
supernatants and the target cells were plated at 50% of confluency. 48 hours post-
transfection, viral supernatants were collected, filtered with 0.45 µm filter, to remove cells 
that were dead or detached from the plate, and supplemented with 8 µg/ml polybrene (this 
is a small, positively charged molecule that binds to cell surfaces and neutralizes surface 
charge, allowing the viral glycoproteins to bind more efficiently to their receptors). 
Supernatants were used to infect human primary fibroblasts. Four rounds of infections, of 4 
hours each, distributed in 2 days, were carried out to have higher infection efficiency. After 
infection, cells were selected with the appropriate antibiotic. 
3.5 Lentiviral infection 
Lentiviruses are a subclass of retroviruses, with the ability to integrate into the genome of 
non-dividing as well as dividing cells. Thus lentiviral infection is amenable for contact 
inhibited or non-cycling senescent cells. Lentiviruses were produced by transfecting HEK 
293T by calcium phosphate method with a vector expressing the gene of interest (10 µg for 
each plate of HEK 293T cells) together with the second-generation packaging vectors 
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expressing the gag, pol, rev and envelope genes. The day after the transfection the growth 
medium was replaced with 5 ml of fresh medium to concentrate viral particles in the 
supernatants. 48 hours post-transfection, viral supernatants were collected, filtered with 
0.45 µm filter, to remove cells that were dead or detached from the plate, and 
supplemented with 8 µg/ml polybrene. Target cells were incubated with the supernatant for 
8-16 hours. After infection, cells were selected with the appropriate antibiotic. 
3.6 Adenoviral infection 
Adenoviruses are non-enveloped viruses and have a dsDNA genome that does not 
integrate into the genome of the infected cells, thus it is not replicated during cell division. 
The recombinant adenoviral vectors are replication deficient and Adeno-293 cells, which 
express genes for viral particle assembly, are used to amplify viral particles. Adeno-293 
cells were plated so they were at around 80% confluency the day of the infection and 
infected with the adenoviral particles (2 plaque forming units/cell) in medium without 
serum for 1 hour and 30 minutes. Infection medium was replaced with DMEM 
supplemented with 5% horse serum. 2-4 days later, cells were lysed by the virus and 
detached from the plate. Culture medium was treated with 3 cycles of freezing and thawing 
(putting it in liquid nitrogen and then in 37°C waterbath) to complete lysis of cells. It was 
centrifuged to eliminate cell debris and supernatant was stored as intermediate stock at -
80°C. The intermediate stock was used for a second round of Adeno-293 infection to 
obtain the final stock. 1 ml of final stock was used to infect 1 well of 6 multi-well plates of 
target cells for 16 hours. 
3.7 Electroporation 
Pulsed electrical fields can be used to introduce DNA into a wide variety of cell lines that 
are refractive to other transfection techniques. BJ hTERT cells were trypsinized and 
around 300000 cells were resuspended in 10 µl resuspension buffer (MPK 1096 kit, Digital 
bio) containing 10 µg DNA. Plasmids were linearized prior to electroporation to facilitate 
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the correct integration in the genome. Cells were electroporated using a microporator 
device (Digital bio) with the following parameters: 1650 V, 1 pulse, 20 ms. Cells were 
plated in a 6 multi-well plate and transfected cells were selected with the appropriate 
antibiotic. 
3.8 Transfection of plasmid DNA in NIH 2/4 cells 
I plated cells in wells of 6 multi-well plates so that they were at around 90% confluency 
the day of the transfection. For each transfection reaction I mixed 250 µl of serum-free 
medium (Opti-MEM) with plasmidic DNA (2 µg final concentration) and 250 µl of Opti-
MEM with 6 µl Lipofectamine 2000 transfection reagent (Life technologies). The two 
solutions were incubated 5 minutes at RT, then mixed and incubated for 20 minutes at RT 
to allow the formation of lipid complexes. The growth medium was removed from the cells 
and substituted with 1.5 ml of Opti-MEM. The mix was added to the cells that were left in 
the incubator for 6 hours, then transfection reaction was removed and fresh culture 
medium was added. 
3.9 RNA interference 
The RNAi pathway is used by the cells for post-transcriptional regulation of endogenous 
genes and to counteract viral invasion and transposon expansion. In cultured cells, short 
synthetic siRNAs are typically used. Alternatively, short hairpin RNA (shRNA) are used in 
vector-based approaches for supplying target sequence designed to form hairpins and loops 
of variable length, which are then processed to siRNAs by the cellular RNAi machinery 
and to produce stable gene silencing. For siRNA transfection, I plated cells in wells of 6 
multi-well plates so that they were at around 30-50% confluency the day of the 
transfection. For each transfection reaction I mixed 250 µl of Opti-MEM with siRNA 
oligos (20 nM final concentration) and 250 µl of Opti-MEM with 4 µl Lipofectamine 
RNAiMAX transfection reagent (Life technologies). The two solutions were mixed and 
incubated for 20 minutes at RT to allow the formation of lipid complexes. The growth 
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medium was removed from the cells and substituted with 1.5 ml of fresh culture medium. 
The mix was added to the cells that were left in the incubator until the analysis. Knock 
down by siRNA transfection is transient, so biological effects are studied within 72 hours 
post transfection. I used SMARTpool siRNA (Thermo Scientific) for mouse Dicer 1 (M-
040892-01), mouse Drosha (M-065630-03) and GFP (P-002048-01). 
3.10 LNA transfection 
Locked nucleic acid (LNA) oligos were transfected as described for siRNAs (see “RNA 
interference” section), with minor modifications. I used 200 nM of LNA oligos for each 
transfection reaction. LNA solution was incubated at 95°C for 5 minutes and chilled in ice 
for 5 minutes, to prevent the formation of secondary structures of the oligos. The 
sequences for LNAs are: 
Cntl: ACTGATAGGGAGTGGTAAACT 
Telo C: CCCTAACCCTAACCCTAACCC 
Telo G: GGGTTAGGGTTAGGGTTAGGG  
3.11 RNase A treatment 
Cells grown on coverlips were washed with PBS, permeabilized with 0.6% Tween 20 in 
PBS for 15 minutes at RT, washed 3 times with PBS and treated with Ribonuclease A 
(RNase A, Sigma-Aldrich, 1 mg/ml) from bovine pancreas or acetylated bovine serum 
albumin (BSA, Sigma-Aldrich, 1 mg/ml) in PBS, for 30 minutes at room temperature 
(RT). Cells were washed with ice cold PBS twice and fixed with 4% paraformaldehyde 
(PFA) for 10 minutes or 1:1 methanol/acetone solution for 2 minutes. For the rescue 
experiment, after RNase A treatment, cells were washed twice with ice-cold PBS, treated 
with an incubation solution containing RNase inhibitor (RNase out, Invitrogen, 1 unit/µl) 
and the RNA Polymerase II and III inhibitor α-amanitin (Sigma-Aldrich, 0.4 µg/ml) for 15 
minutes at RT. They were then incubated in the same solution with 200 ng of total cellular 
RNA, or tRNA, for additional 15 minutes at RT. They were fixed with 4% PFA for 10 
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minutes or 1:1 methanol/acetone solution for 2 minutes. In order to avoid the loss of small 
RNAs, total RNA from cells was extracted using mirVana kit (Life technologies) 
according to manufacturer's instructions. 
3.12 Indirect immunofluorescence in cultured cells 
The study protein sub-cellular localization at the single cell level I used specific antibodies 
by immunofluorescence techniques. Cells were grown on coverslips, washed twice for 5 
minutes with PBS and fixed with either 1:1 methanol/acetone solution for 2 minutes at RT 
or with 4% PFA for 10 minutes at RT. In case of PFA fixation, cells were permeabilized 
with 0.2% Triton X-100 for 10 minutes at RT. Cells were incubated for 1 hour in blocking 
solution (PBG, 0.5% BSA, 0.2% gelatin from cold water fish skin) and then stained with 
primary antibodies diluted in PBG for 1 hour at RT in a humidified chamber. Cells were 
washed 3 times for 5 minutes with PBG and incubated with secondary antibodies diluted in 
PBG for 1 hour at RT in a dark humidified chamber. Cells were washed twice for 5 
minutes with PBG, twice for 5 minutes with PBS and incubated with 4'-6-Diamidino-2-
phenylindole (DAPI, 1µg/ml, Sigma-Aldrich, excitation wavelength 358nm, emission 
wavelength 461nm) for 2 minutes at RT. DAPI binds preferentially to AT clusters of DNA 
minor groove and it was used to visualize nuclei. Cells were briefly washed with PBS and 
water and coverslips were then mounted with mowiol mounting medium (Calbiochem), 
which is a polyvinyl alcohol solution containing an "anti fade" agent which is capable of 
reducing light-induced fading (photobleaching) of the fluorophore. Coverslips were air 
dried before microscope analysis.  
3.13 Indirect immunofluorescence in mouse and baboon tissues 
Frozen tissues placed in OCT were thawed, fixed for 20 minutes in 4% formaldehyde at 
RT and washed 3 times for 5 minutes with PBS. Samples were permeabilized with 0.5% 
Triton X-100 in PBS for 5 min at RT and washed twice for 5 minutes with PBS. 
Unspecific sites were blocked in 5% goat serum, 1% BSA diluted in PBS for 1 hour at RT. 
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Primary antibody diluted in 2.5% goat serum, 1% BSA in PBS was incubated over night at 
4°C in a humidified chamber. Samples were washed 3 times for 10 minutes with PBS. 
Secondary antibody diluted in 1% BSA in PBS was incubated for 1 hour at RT in a dark 
humidified chamber. Samples were washed 3 times for 10 minutes with PBS. DAPI 
staining was used to detect nuclei and mowiol solution to mount coverslips. Mouse tissues 
were provided by Christian M. Beausejour, Université de Montréal & Centre Hospitalier 
Universitaire Sainte-Justine, Montréal, Canada; all in vivo manipulations were approved by 
the Comité Institutionnel des Bonnes Pratiques Animales en Recherche (CIBPAR) of 
CHU-Ste-Justine. Brain tissues from 3 mice (2 months old) were analyzed. Baboon tissues 
were provided by Utz Herbig, NJMS-UH Cancer Center (Newark, NJ, USA); all 
procedures were approved by the Institutional Animal Care and Use Committee (IACUC). 
The SBRF animal program has been accredited by the Association for the Assessment and 
Accreditation of Laboratory Animal Care, International (AAALAC) since 1973. Brain 
tissue from 4 old baboons (325-353 months old) and 2 young baboons (58 and 88 months 
old) were analyzed. 
3.14 Immunofluorescence and Fluorescence In Situ Hybridization 
(ImmunoFISH)  
ImmunoFISH technique combines the immunofluorescence with an antibody that 
recognizes a cellular antigene and FISH with a probe that detects the presence of specific 
DNA sequences on chromosomes in metaphase or interphase cells. The binding to its 
target can be identified by a distinct fluorescence signal. A Peptide Nucleic Acid (PNA) 
probe is a synthetic DNA/RNA analogue capable of binding to DNA/RNA in a sequence-
specific manner obeying the Watson-Crick base paring rules. In PNA molecules, a neutral 
peptide/polyamide backbone keeps the distances between the bases exactly the same as in 
DNA and gives PNA excellent properties for hybridizing to DNA or RNA. In addition, 
PNAs are highly resistant to degradation by DNases, RNases, proteinases and peptidases 
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and are superior to DNA probes in terms of sensitivity and specificity. The fluorescence 
intensity of the spots is directly correlated to the length of the telomeres, thus it allows an 
exact measurement of the telomere length (Lansdorp et al., 1996). 
Cells or tissues were fixed and probed as described in the corresponding 
immunofluorescence sections. Subsequently, after secondary antibodies incubation and 
washes, samples were fixed with 4% PFA and 0.1% Triton X-100 for 10 minutes at RT 
and reaction was then blocked with 100 mM Glycin, for 30 minutes at RT. Samples were 
washed 3 times with PBS and DNA was denaturated at 80°C for 5 minutes under a glass 
coverslip in the presence of the Cy3-conjugated telomeric PNA probe (Panagene, 
excitation wavelength 550 nm, emission wavelength 570 nm) in hybridization solution 
(70% formamide, 0.25% blocking reagent Roche, 10 mM Tris HCl pH 7.4, 0.5 µM 
telomeric PNA probe). The hybridization process took place in a dark humidified chamber 
at RT for 2 hours. Samples were washed twice for 15 minutes in wash solution I (70% 
formamide, 0.1% BSA, 10 mM Tris HCl pH 7.4) and twice for 5 minutes in wash solution 
II (100 mM Tris HCl pH 7.4, 150 mM NaCl, 0.08% Tween 20). They were stained with 
DAPI for 2 minutes, briefly washed with PBS and water and mounted with mowiol. 
3.15 BrdU incorporation assay 
To monitor DNA replication during S phase of the cell cycle, cells were incubated with 5- 
bromodeoxyuridine (BrdU, Sigma-Aldrich, 10 µg/ml) for 16-24 hours. BrdU is a synthetic 
nucleoside analogue of thymidine, and is incorporated into replicating DNA. Incorporation 
can be evaluated by immunofluorescence after DNA denaturation. Denaturation can be 
achieved by treatment with acids or alkali, or by a mild treatment with a nuclease that 
digest DNA to allow antibody access, simultaneously with antibody incubation. Cells, 
plated on coverslips, were fixed with 4% PFA for 10 minutes and permeabilized with 0.2% 
Triton X-100 for 10 minutes at RT. After blocking with PBG for 1 hour, cells were 
incubated with a mixture containing primary antibody (anti-BrdU, 1:20), DNase (Promega, 
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0.1 U/µl,), DNase buffer and MgCl2 (3 mM) for 45 minutes at RT. Cells were washed 3 
times with PBG and incubated with secondary antibody diluted in PBG for 40 minutes at 
RT. Cells were washed twice with PBG and twice with PBS. DAPI staining was used to 
detect nuclei and mowiol solution to mount coverslips. 
3.16 BrdU detection under non-denaturing condition  
This protocol has already been used to detect ssDNA upon replicative stress (Ye et al., 
2010). Cells were incubated with BrdU (Sigma-Aldrich, 10 µg/ml) for 24 hours, so that 
virtually all cells had the chance to incorporate the nucleotide analogue. Cells grown on 
coverslips were washed twice with ice-cold PBS and treated with ice-cold cytoskeleton 
buffer (10 mM Pipes pH 6.8, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 1 mM 
EGTA, 0.5% Triton X-100) for 5 minutes on ice and subsequently with cytoskeleton 
stripping buffer (10 mM Tris HCl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 1% Tween 40, 
0.5% sodium deoxycholate) for 5 minutes on ice. Cells were washed 3 times for 5 minutes 
with ice-cold PBS, fixed with 4% formaldehyde for 20 minutes at RT and permeabilized 
with 0.5% Triton X-100 for 15 minutes at RT. They were washed 3 times for 5 minutes 
with PBS and unspecific epitopes were blocked with 5% BSA in PBST (0.1% Tween 20 in 
PBS) for 45 minutes at RT. They were incubated with primary antibody diluted in PBST-
2% BSA for 1 hour at RT in a humidified chamber and washed 3 times for 5 minutes in 
PBST. They were incubated with secondary antibody diluted in PBST-2% BSA for 45 
minutes at RT in a dark humidified chamber and washed twice for 5 minutes in PBST and 
once for 5 minutes in PBS. DAPI staining was used to detect nuclei and mowiol solution to 
mount coverslips. As a control for the efficient BrdU incorporation, additional coverslips 
cells were also stained for BrdU signal in denaturing conditions (see “BrdU staining under 
non-denaturing condition” section). 
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3.17 Senescence-associated-β-galactosidase assay 
The activity of SA-β-gal is a widely used biomarker of cellular senescence, because β-
galactosidase is specifically active at pH 6.0 in senescent cells, while its activity at this pH 
is poorly detectable in pre-senescent, quiescent or immortal and transformed cells (Dimri 
et al., 1995). Cells were grown on coverslips, washed in PBS, fixed in 4% PFA for 10 
minutes at RT, washed again and incubated at 37°C in the absence of CO2 with fresh SA-
β-gal stain solution (1 mg/ml 5-bromo-4-chloro-3-indolyl beta-D-galactopyranoside, 0.5 M 
phosphate buffer at pH 6.0, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 
150 mM NaCl, 2 mM MgCl2). Staining was evident after 2-4 hours and maximal after 12-
16 hours. At the end of the incubation time, cells were washed with PBS, fixed with 4% 
PFA for 10 minutes at RT, permeabilized with 0.2% Triton X-100 for 10 minutes at RT, 
washed with PBS, incubated with DAPI for 2 minutes, washed with PBS and mounted 
with mowiol. SA-β-gal staining is detected in senescent human fibroblasts as a local 
perinuclear blue precipitate. 
3.18 Imaging 
Immunofluorescence and immunoFISH images were acquired using a wide field Olympus 
Biosystems Microscope BX61 or a Leica TCS SP2 AOBS confocal laser microscope. To 
allow a more accurate signals discrimination and detection of co-localization events, 
confocal sections were obtained by acquisition of optical z-sections at different levels 
along the optical axis. Co-localization between DDR and telomeres was assessed by 
ImageJ software with co-localization ImageJ plug-in on confocal 3D stacks. Two points 
were considered co-localizing if their respective intensities were higher than the threshold 
of their channels, and if the ratio of their intensity was higher than the ratio setting value. 
Comparative immunofluorescence analyses were performed in parallel with identical 
acquisition parameters. Telomere length was analyzed by quantification of telomeric signal 
fluorescence intensities by ImageJ software. SA-β-gal images were acquired using a wide 
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field Olympus Biosystems Microscope IX 81. Comparative imaging analyses were 
performed in parallel with identical acquisition parameters.  
3.19 Immunoblotting 
Cells were lysed in Laemmli sample buffer (2% sodium dodecyl sulphate (SDS), 10% 
glycerol, 60 mM Tris HCl pH 6.8). SDS is an anionic detergent, which denatures 
secondary and tertiary protein structures providing a uniform negative charge along the 
length of the polypeptide, thus allowing separation by electrophoresis only by molecular 
weight. The amount of proteins in the samples was measured by the biochemical Lowry 
protein assay. Copper (II) ions in alkaline solution react with protein to form complexes, 
and with the Folin-phenol reagent, a mixture of phosphotungstic acid and 
phosphomolybdic acid in phenol. The product becomes reduced to molybdenum/tungsten 
blue and can be detected colorimetrically by absorbance at 750 nm. A tracking dye, 
bromophenol blue, was added to the protein solution to allow the tracking of the proteins 
through the gel during the electrophoretic run. Disulfide linkages were reduced by adding 
β-mercaptoethanol and proteins were further denatured by heating at 95°C for 5 
minutes. 50 µg of whole cell extracts were resolved by SDS polyacrylamide gel 
electrophoresis (SDS-PAGE). Protein solution run is performed in two layers of gel, 
namely stacking or spacer gel and resolving or separating gel. The stacking gel is a large 
pore 4% polyacrylamide gel in which proteins are concentrated. It is prepared with Tris 
HCl buffer at pH 6.8. This gel is cast over the resolving gel, which is a small pore 
polyacrylamide gel. The Tris HCl buffer used is at pH 8.8. Resolving gel is used for 
separating different range of proteins. I commonly used 6% gel for > 100 kDa proteins, 
10% gel for 40-100 kDa proteins and 15% gel for < 40 kDa proteins. After running in 
running buffer (25 mM Tris HCl, 0.2 M glycine, 0.1% SDS, pH 8.3), the proteins were 
transferred to nitrocellulose membrane by a wet electroblotting transfer method with 
transfer buffer (25 mM Tris HCl, 0.2 M Glycine, 20% methanol). Following protein 
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transfer, membranes were temporarily stained with Ponceau to assess the transfer 
efficiency. Ponceau is a negative stain, which binds to the positively charged amino groups 
of the protein and it also binds non-covalently to non-polar regions of the protein. Blocking 
of unspecific sites and primary and secondary antibody incubations were carried out in 5% 
milk in TBST (0.1% Tween in Tris-Buffered Saline). All the washes between incubations 
were performed in TBST. The primary antibody is specific for the protein of interest, 
whereas the secondary antibody is a modified antibody, which is linked to the horseradish 
peroxidase enzyme that, in the presence of the acridan-based substrate, produces localized 
light in the region where the antibody is bound to the membrane. The localized light, 
which is emitted from the bands, was detected by photosensitive photographic film. This 
method of detection is called chemiluminescence. 
3.20 Quantitative reverse PCR (qRT-PCR) 
Total RNA from cultured cells was extracted with RNeasy Mini Kit (Qiagen), according to 
manufacturer's instructions and quantified with NanoDrop spectrophotometer (Thermo 
Scientific). 1 µg of RNA was retrotranscribed using SuperScript VILO cDNA Synthesis 
Kit, according to manufacturer's instructions. A volume corresponding to 10 ng of initial 
RNA was used for each qPCR reaction.  
The Real Time PCR Instrument allows real time detection of PCR products as they 
accumulate during PCR cycles. In the initial cycles of PCR, the low fluorescence defines 
the baseline for the plot of fluorescence signal vs cycle number. A fixed fluorescence 
threshold can be set above the baseline. The parameter Ct (threshold cycle) is defined as 
the cycle number at which the fluorescence becomes higher than the fixed threshold. Thus, 
the higher the initial amount of the sample, the sooner accumulated product is detected in 
the PCR process as a significant increase in fluorescence, and the lower the Ct value. Ct 
values are very reproducible in replicates because the threshold is detected in the 
exponential phase of the PCR, where there is a linear relation between log of the change in 
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fluorescence and cycle number. When the Ct values were higher than 35, PCR result was 
classified as undetermined.  
The Sybr Green-based qPCR experiments were performed on a Roche LightCycler 480 
sequence detection system in triplicate. Sybr Green binds to all double-stranded DNA 
species present in the sample, thus during the reaction the fluorescence intensity increases 
proportionally to the amount of PCR product. Ribosomal protein large P0 (Rplp0) was 
used as a control gene for normalization. qPCR primers were:  
Dicer1 Fw: GCAAGGAATGGACTCTGAGC 
Dicer1 Rv: GGGGACTTCGATATCCTCTTC 
Drosha Fw: CGTCTCTAGAAAGGTCCTACAAGAA 
Drosha Rv: GGCTCAGGAGCAACTGGTAA 
Rplp0 Fw: TTCATTGTGGGAGCAGAC 
Rplp0 Rv: CAGCAGTTTCTCCAGAGC 
The Taqman-based qPCR experiments and the following analyses were carried in triplicate 
by the Real Time PCR unit (Cogentech) at the IFOM-IEO Campus, Milan, Italy, using the 
ABI 7900HT sequence detection system and 7500 Real-Time PCR system (Life 
Technologies). A gene-specific probe carrying two dyes, the fluorescent reporter and the 
quencher, hybridizes to the amplicon during the PCR reaction. The two fluorescent dyes 
interact whenever the probe is intact, causing the quencher dye to quench the reporter dye. 
During the amplification, the Taq DNA polymerase cleaves the 5 ́ end of the probe, 
releasing the quencher dye resulting in an increase in fluorescence. The change in reporter 
dye fluorescence is quantitative for the amount of PCR product. Beta-2-microglobulin 
(B2M) was used as a control gene for normalization. The following assays were used from 
Applied Biosystems: Hs00606991_m1 (KI-67), Hs99999907_m1 (B2M). 
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3.21 Plasmids and cloning 
Retroviral vectors pRetroSuper shGFP and pRetroSuper shKAP-1 were gifts from Penny 
Jaggo, University of Sussex, Brighton, UK. Lentiviral vectors expressing GFP and TRF2, 
and packaging vectors Gag/Pol 8.91 plasmid (encoding for gag, pol and rev genes) and 
VSV-G (encoding for envelope elements) were gifts from Eric Gilson, IRCAN, Nice, 
France. Telo plasmid is a pSP73 plasmid containing 135 TTAGGG repeats and was a gift 
from Titia de Lange, Rockfeller University, New York, NY, USA; I-SceI + Telo plasmid 
was generated by cloning the I-SceI restriction site in the Telo plasmid; I-SceI plasmid was 
generating from the I-SceI + Telo plasmid, removing the TTAGGG repeats. Cherry-LacI, 
CFP-LacI, YFP-Tet and RFP-ISceI-GR vectors (Soutoglou et al., 2007; Soutoglou and 
Misteli, 2008) were gifts from Evi Soutoglou, IGBMC, Strasbourg, France. LacI vector 
was generated from the Cherry-LacI plasmid, removing the Cherry coding DNA sequence 
(CDS). LacI-TRF2 vector was generated by in frame cloning of the TRF2 CDS (amino 
acids 29-446) in the LacI vector. LacI-TRF1 vector was generated by in frame cloning of 
the TRF1 CDS (amino acids 1-378) in the LacI vector. YFP-Tet-TRF2 was generated by in 
frame cloning of the TRF2 CDS (amino acids 29-446) in the YFP-Tet vector. Adeno GFP 
was a gift from Elisabetta Dejana, IFOM, Milan, Italy. Adeno I-SceI was a gift from Philip 
Ng, Baylor College of Medicine, Huston, Texas, USA). 
3.22 Antibodies 
Anti-γH2AX (Millipore 05-636, 1:200); anti-ATM pS1981 (mouse, Rockland 200-301-
400, 1:400; rabbit, Abcam ab2888, 1:300; mouse, Millipore 05-740, 1:100); anti-pS/TQ 
(Cell Signalling 2851, 1:200); anti-53BP1 (mouse, a gift from Thanos Halazonetis, 
University of Geneva, Geneva, Switzerland, 1:20; rabbit, Novus NB100-304, 1:200); anti-
MDC1 (a gift from Jiri Bartek, IMG, Prague, Czech Republic, 1:20); anti-BrdU 
(denaturing conditions: Becton Dickinson 347580, 1:20; non-denaturing conditions: 
Abcam ab6326, 1:200); anti-CENP-C (a gift from Andrea Musacchio, Max Planck 
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Institute, Dortmund, Germany, 1:1000); anti-CREST (Antibodies Incorporated 15-234, 
1:100); anti-CHK2 pT68 (Cell Signalling 2661, 1:100); anti-TRF2 (Upstate 05-521, 
1:500); anti-LacI (Abnova PAB10255, 1:400); anti-FLAG (Sigma-Aldrich F3165, 1:500); 
anti-KAP-1 (Abcam ab10484, 1:1000); anti-AcH4 (a gift from Saverio Minucci, IEO, 
Milan, Italy, 1:1000); anti-H3 (Abcam ab10799, 1:1000); anti-Vinculin (Signa-Aldrich 
V9131, 1:2000); anti tubulin (Sigma-Aldrich T5168, 1:2000); anti GFP (Abcam ab290, 
1:2500). As secondary antibodies I used goat anti-rabbit Alexa 405 IgG (Life 
Technologies, 1:100, excitation wavelength 401 nm, emission wavelength 421 nm); 
donkey anti-mouse or anti-rabbit Alexa 488 IgG (Life Technologies, 1:100, excitation 
wavelength 495 nm, emission wavelength 519 nm); donkey anti-rat FITC IgG (Jackson 
Immuno Research, 1:50, excitation wavelength 495 nm, emission wavelength 519 nm); 
donkey anti-mouse or anti-rabbit Cy3 IgG (Jackson Immuno Research, 1:400, excitation 
wavelength 550 nm, emission wavelength 570 nm), donkey anti-mouse or anti-rabbit 
Alexa 647 IgG (Life Technologies, 1:100, excitation wavelength 650 nm, emission 
wavelength 665 nm). 
3.23 Statistical analyses 
Results are shown as means plus minus standard error of the mean (s.e.m.) or standard 
deviation (s.d.) as indicated. p-values were calculated by chi-square test with 1 degree of 
freedom for qualitative data. 
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4 Results 
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4.1 Irradiation-induced cellular senescence is associated with a 
persistent DNA damage response activation at the telomeres 
4.1.1 Ionizing radiations induce persistent DNA damage and cellular senescence  
The generation of DNA damage is a harmful event for cells, because it can lead to cell 
death and genomic instability. Different repair pathways have evolved to cope with various 
endogenous or exogenous DNA lesions. Surprisingly, previous work in the lab showed that 
not all the DNA damage could be repaired. In this regard, early passage contact-inhibited 
BJ cells, were exposed to high dose (20 Gy) of IR. Since the cells did not proliferate, no 
telomere shortening, a potential trigger of cellular senescence (Bodnar et al., 1998) could 
occur. To study DDR activation, cells were fixed at different time points following 
irradiation and stained for nuclear foci containing the phosphorylated histone H2AX 
(γH2AX) and proteins phosphorylated by the activated form of ATM or ATR (pS/TQ) 
(Fig. 4a). Despite an efficient wave of repair leading to a dramatic reduction in the number 
of DDR foci per cell, not all of them disappeared and, even four months post-irradiation, 
some foci could still be detected and most cells were DDR-positive (Fig 4b,c). These few 
but persisting DDR signalling events were responsible for the establishment of cellular 
senescence in these cells (hereafter named IrrSen), as shown by inability to incorporate 
BrdU, upon release from contact inhibition, and high SA-β-gal activity (Fumagalli et al., 
2012). However it was not clear whether the inability to repair in full the DNA damage 
was a consequence of the acute high dose of IRs used in the experiment. In order to 
address this point, I irradiated contact-inhibited BJ hTERT cells with a single high dose 
(20 Gy), or a fractionated low dose repeated each day (2 Gy x 10) or a single low dose (2 
Gy) of IR. Thirty days after treatment, I fixed irradiated and non-irradiated cells and 
immunostained them for 53BP1 as a DDR marker (Fig. 5a). Cells irradiated with 20 Gy 
both in a single or fractionated dose showed a comparable number of persistent 53BP1 foci 
and comparable fraction of 53BP1-positive cells.  
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Results by Marzia Fumagalli; adapted from (Fumagalli et al., 2012) 
Figure 4. Ionizing radiations induce persistent DNA damage response activation in human cells.  
BJ cells were irradiated with 20 Gy and stained at the indicated time points following irradiation. (a) 
Representative images of γH2AX and pS/TQ immunostaining, acquired by widefield microscopy. (b) 
Quantification of γH2AX-positive cells and (c) number of γH2AX foci per cell. (For the quantification 
shown, around 100 cells per sample from 1 experiment were analysed; error bars represent s.e.m.).  
 
Of note, also in cells irradiated with 2 Gy, some persistent 53BP1 foci were still detectable, 
although in a lower fraction of cells (Fig. 5b,c). This suggests that, independently from the 
type of irradiation, while the majority of DDR foci are transient and thus inconsequential 
for cell proliferation, few DDR foci resist repair and seem sufficient to maintain cellular 
senescence and impair the ability of cells to recover and proliferate. 
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Figure 5. Ionizing radiations induce persistent DNA damage response, independently from the amount 
of DNA damage.  
BJ hTERT cells were irradiated with 2 Gy, 2 Gy per day for 10 days, and 20 Gy and stained 30 days later. (a) 
Representative images of 53BP1 immunostaining, acquired by widefield microscopy. (b) Quantification of 
53BP1-positive cells and (c) number of 53BP1 foci per cell. (For the quantification shown, around 200 cells 
per sample from 1 experiment were analysed; error bars represents s.e.m.). 
4.1.2 Irradiation-induced cellular senescence is ATM-dependent 
It has been previously shown that an active DDR is necessary for initiation and 
maintenance of replicative and oncogene-induced senescence (d'Adda di Fagagna et al., 
2003; Herbig et al., 2004). Thus I asked whether a similar mechanism was in place also in 
IR-induced senescence. I treated IrrSen BJ hTERT cells with an inhibitor of ATM kinase 
activity and monitored ATM inhibition by the loss of ATM-dependent CHK2 
phosphorylation (CHK2 pT68). In virtually all cells the CHK2 pT68 signal disappeared 
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after 24 hours of treatment (Fig. 6). Inhibition of ATM caused a prompt escape from 
senescence, already two days after the treatment, as shown by an increase in BrdU 
incorporation rates (Fig. 7). 
 
Figure 6. CHK2 phosphorylation is lost upon treatment with an ATM inhibition in IrrSen cells.  
IrrSen BJ hTERT cells were treated with the ATM inhibitor KU55933 (ATMi; 10 µM) or vehicle alone 
(DMSO). Representative images of CHK2 pT68 immunostaining, acquired by widefield microscopy. Upon 
ATMi treatment, ATM-dependent CHK2 phosphorylation is lost, indicating ATM inhibition. 
 
Figure 7. ATM inhibition leads to increased proliferation in IR-induced senescent cells.  
IrrSen BJ hTERT cells were treated with the ATM inhibitor KU55933 (ATMi; 10 µM) or vehicle alone 
(DMSO). Quantification of BrdU-positive cells after 24 hours BrdU pulses at the indicated time points after 
ATMi treatment (** p-value < 0.01, *** p-value < 0.001, calculated by chi square test; for the quantification 
shown, around 600 cells per sample were analysed; n = 3 independent experiments; error bars represent 
s.e.m.). 
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As an independent evidence of re-entry in the cell cycle, I analysed the expression levels of 
KI-67, a marker of cell proliferation. Consistent with the previous result, the mRNA levels 
of KI-67 were five fold higher in treated cells, compared with controls (Fig. 8). These data 
reveal that, as for the replicative senescence, a sustained DDR is constantly and actively 
maintained and that this signalling is necessary for IR-induced senescence maintenance.  
 
Figure 8. ATM inhibition leads to increased expression levels of the proliferation marker KI-67.  
IrrSen BJ hTERT cells were treated with the ATM inhibitor KU55933 (ATMi; 10 µM) or vehicle alone 
(DMSO). Triplicate qPCR reactions with Taqman chemistry show an increase of KI-67 mRNA levels in 
ATMi-treated cells. (Error bars represent s.d.). 
 
In addition, consistent with a published report (Rodier et al., 2011), IrrSen cells showed 
focal accumulation of the activated form of CHK2, which co-localized with persistent 
H2AX foci, whereas freshly irradiated cells show a more diffuse nuclear staining (Fig. 9). 
This suggests that DNA damage that is not promptly resolved causes downstream DDR 
factors (such as CHK2) to be retained longer at lesion sites. A focal accumulation of 
CHK2 pT68 signal co-localizing with telomeres has already been observed for replicative 
senescent cells (Herbig et al., 2004).  
4.1.3 Differential DDR activation in different cell type during senescence establishment 
In apparent contrast with our and other groups’ results (d'Adda di Fagagna et al., 2003; 
Herbig et al., 2004; Sedelnikova et al., 2004), some published reports described that 
initially upon senescence establishment DDR foci are detectable, but then are lost in deep 
senescent cells (Bakkenist et al., 2004; Chen and Ozanne, 2006). The novel results 
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described here about IR-induced senescence support the former hypothesis that DDR foci 
persist.  
 
Figure 9. Activated CHK2 forms discrete nuclear foci that co-localize with persistent γH2AX only in 
IrrSen cells.  
Representative images of CHK2 pT68 and γH2AX immunostaining, acquired by widefield microscopy. 
Twenty minutes (freshly irr) after IR (1 Gy), CHK2 pT68 shows a diffuse staining. Differently, in IrrSen BJ 
hTERT cells, it accumulates in foci co-localizing with γH2AX. The percentage of co-localization between 
CHK2 pT68 and γH2AX (± s.e.m.) is indicated. 
 
I therefore decided to extend my analysis to other normal human fibroblasts cell lines, 
IMR-90 (that were used in the above mentioned studies), and WI-38. I irradiated early 
passage, contact-inhibited BJ, WI-38 and IMR-90 cells and stained them for 53BP1 as a 
DDR marker. These cells showed a comparable number of DDR foci immediately (one 
hour) after low dose irradiation (Fig. 10a). Differently, at later time points (3, 10 and 30 
days) post irradiation (20 Gy), while WI-38 had an apparent similar kinetics of DDR foci 
resolution compared to BJ, IMR-90 showed a reproducibly lower number of 53BP1 foci 
per cell and lower fraction of 53BP1-positive cells at various time points (Fig. 10b-c). This 
is consistent with what was observed in replicative senescent cells (Bakkenist et al., 2004; 
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Chen and Ozanne, 2006), and it suggests that the presence of persistent DDR foci upon 
senescence establishment can be cell line-specific.  
 
 
Figure 10. Different cell lines show an apparently differential persistence of DNA damage response 
activation upon senescence establishment.  
(a) BJ hTERT, WI-38 and IMR-90 cells were irradiated with 1 Gy and stained 10 minutes later. 
Quantification of number of 53BP1 foci per cell. (For the quantification shown, around 50-100 cells per 
sample from 1 experiment were analysed; error bars represent s.e.m.). (b-c) BJ hTERT, WI-38 and IMR-90 
cells were irradiated with 20 Gy and stained for 53BP1 as a DDR marker thirty days later. Bar graphs show 
the quantification of 53BP1-positive cells and number of 53BP1 foci per cell. (For the quantification shown, 
around 50-100 cells per sample were analysed; n = 2 independent experiments; error bars represent s.e.m.). 
 
This apparent inconsistency among cell lines could be explained by the higher sensitivity 
to stress of IMR-90 compared to the other cell types. To address this, I exposed the three 
cell lines to high doses of IR and observed their survival at different time points following 
irradiation. I observed a massive cell death in IMR-90 upon irradiation and, to a minor 
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extent, also in non-irradiated cells, while in BJ hTERT and WI-38 cell number remained 
almost constant (Fig. 11).  
 
Figure 11. Apparent differential DNA damage response activation during senescence correlates with 
cell survival upon DNA damage.  
BJ hTERT, WI-38 and IMR-90 cells were irradiated or not with 20 Gy. Graphs show the average cell number 
of triplicates at different time points, in irradiated cells and non-irradiated controls (error bars represent 
s.e.m.). 
 
I tested the hypothesis that these cells died by apoptosis, but the absence of detectable 
levels of cleaved caspase-3 by immunoblot staining suggested that this was not the case 
(Fig. 12).  
 
Figure 12. IR-induced cell death is not associated with apoptosis marker.  
BJ hTERT, WI-38 and IMR-90 cells were irradiated with 20 Gy and protein lysates were collected 30 days 
later. Cleaved caspase-3 signal was detected only in irradiated TALL-1 cells, used as a positive control for 
apoptosis activation. Ponceau staining was used as a loading control. 
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Thus the difference in DDR activation at the time of senescence establishment could be 
explained by a cell-specific sensitivity to stress likely associated with culture shock, so that 
the cells with more unrepaired DNA damage preferentially die. We conclude that indeed 
DDR foci in senescent cells are persistent, rather it is the prolonged cell viability of some 
cell lines that does not allow their accurate study in time.  
4.1.4 Persistent DNA damage response foci localize preferentially at telomeres, 
independently from the amount of DNA damage  
The molecular bases that distinguish reparable,	   transient DDR foci from irreparable,	  
persistent DDR foci were unknown. Telomeres are genomic loci made of repetitive DNA 
sequences coated by specific proteins that inhibit DNA repair at chromosome termini to 
prevent chromosomal fusions and genome instability (O'Sullivan and Karlseder, 2010). We 
hypothesized that they could be genomic loci that resist cellular DNA-repair activities 
when a DSB occurs within the telomere length. This hypothesis is supported by in vitro 
assays using human cell extracts, in which NHEJ is inhibited at telomeric DNA ends (Bae 
and Baumann, 2007; Bombarde et al., 2010). Previous experiments in our group aimed to 
test this hypothesis. Therefore, interphase BJ cells were stained for the DDR factor 53BP1, 
in conjunction with FISH using a telomeric Cy3-conjugated PNA probe (immunoFISH) at 
different time points following exposure to IR (Fig. 13a). Optical z-sections acquired by 
confocal microscopy were used to perform a manual 3D analysis, followed by a software-
based quantification. We showed that while the number of 53BP1 foci per cell 
progressively declined with time, the fraction that co-localized with a telomeric signal 
gradually increased up to 30%. In contrast, this was not evident looking at the co-
localization between the DDR marker and another repetitive DNA region, the centromeres, 
visualized by CENP-C staining (Fig. 13b). A very similar result was reproduced using 
MRC-5 cells, another human fibroblast cell line (Figs. 13c,d).  
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Results by Marzia Fumagalli; adapted from (Fumagalli et al., 2012) 
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Figure 13. Persistent DDR preferentially co-localizes with telomeric DNA in human cells.  
Contact-inhibited BJ (a,b) and MRC-5 (c,d) cells were irradiated and analysed at the indicated time points. 
(a,c) Representative images acquired by confocal microscopy show co-localization between 53BP1 and 
telomeres, detected using a telomeric PNA probe (Telo), or centromeres detected by antibodies raised against 
a centromeric protein (CENP-C). (b,d) Quantification of the percentage of co-localizations between 53BP1 
foci and telomeric (Telo) or centromeric (CENP-C) regions, and the average number of 53BP1 foci per cell. 
(For the quantifications shown, around 50-200 cells per time point from 1 experiment were analysed; error 
bars represent s.e.m.). 
 
The length of the human genome is around 3 billions bp, while each telomere is around 10 
Kb long. Thus the observed extent of co-localization is highly significant, since telomeric 
DNA in human cells accounts for around 0.014% of the genome. 
To extend this observation in vivo, mice were irradiated with a sub-lethal dose of total 
body IR (8 Gy) and hippocampal sections were stained 6 hours and 12 weeks after 
irradiation for 53BP1 and the telomeric PNA probe or the centromeric marker CREST 
(Fig. 14a). Consistent with observations in cultured cells, with time, hippocampal neurons 
are able to repair most of the DDR foci and 12 weeks after irradiation the percentage of co-
localization of DDR with the telomeric signals increased up to 40%, while the fraction co-
localizing with the centromeres remained constant (Fig. 14b). 
To make sure that the accumulation of DDR markers at telomeres was not due to the high 
acute dose of IR, I performed the same co-localization analysis between telomeres and 
53BP1 in BJ hTERT cells irradiated with 20 Gy, 2 Gy per day for 10 days, and 2 Gy (Fig 
15a). IR is expected to generate DNA damage and DDR foci randomly in the genome. 
When most of DNA damage is repaired, the fraction of persisting DDR foci at telomeres 
should be constant and independent from the initial amount of DNA damage. Indeed, 30 
days after irradiation, cells showed a comparable fraction of 53BP1 foci co-localizing with 
the telomeric PNA probe, in the three different conditions (Fig. 15b), despite the different 
number of DDR foci per cell (Fig. 5).  
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Results by Marzia Fumagalli; adapted from (Fumagalli et al., 2012) 
Figure 14. Persistent DDR preferentially co-localizes with telomeric DNA in vivo, in mouse 
hippocampal neurons.  
Hippocampal neurons from adult mice were analysed at the indicated timepoints post IR (8 Gy). (a) 
Representative images acquired by confocal microscopy show co-localization between 53BP1 and telomeres, 
detected using a telomeric PNA probe (Telo), or centromeres detected by a specific antibody (CREST). (b) 
Quantification of the percentage of co-localizations between 53BP1 foci and telomeric (Telo) or centromeric 
(CREST) regions, and the average number of 53BP1 foci per cell. (For the quantification shown, around 400 
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cells per time point were analysed; samples from 3 individual mice were analysed; error bars represent 
s.e.m.). 
 
 
Figure 15. Persistent DDR foci localize preferentially at telomeres in cells irradiated with low dose or 
fractionated IR.  
BJ hTERT cells were treated with the indicated dose of IR and stained 30 days later. (a) Maximum 
projections of Z-stacks acquired by confocal microscopy show co-localizations between DDR foci, detected 
as 53BP1 foci, and telomeres, detected using a telomeric PNA probe (Telo). (b) Quantification of 53BP1 foci 
co-localizing with telomeres upon the different irradiation treatments. (For the quantification shown, around 
20 cells per sample from 1 experiment were analysed; error bars represent s.e.m.). 
 
4.1.5 In human cells a DNA double-strand break close to telomeric repeats results in a 
more persistent DNA damage response  
Since a high fraction of persistent DDR foci co-localized with telomeric DNA, I 
hypothesized that this was the consequence of the impaired capability of telomeric DSB to 
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be repaired. In order to directly address this, I generated three stable cell lines by 
electroporation of different constructs in BJ hTERT cells. The first plasmid carried a site 
for the restriction endonuclease I-SceI a yeast endonuclease that recognizes a 18-
nucleotide long sequence not found in the mammalian genome. This site was flanked by 
135 telomeric repeats (Telo + I-SceI). Importantly, I cloned the I-SceI site downstream the 
telomeric repeats because in vitro assays showed that the telomeric effect in inhibiting 
NHEJ was directional and toward the 3’ direction (Bae and Baumann, 2007). I also 
generated stable cell lines carrying the telomeric repeats only (Telo), or the I-SceI site with 
no telomeric DNA (I-SceI), to be used as controls (Fig. 16a). I isolated and cultured 
homogeneous clonal cell populations till confluency, then infected them with an 
adenovirus expressing the I-SceI endonuclease and analyzed the DDR activation in the 
form of 53BP1 foci. One day after the infection most cells were DDR-positive, even in 
Telo cells, that did not have an I-SceI site (Fig. 16b). This is likely due to adenoviral 
infection per se – also cells infected with a GFP-expressing adenovirus showed a similar 
DDR activation. Seven days after the infection, around 40% of GFP-expressing cells were 
still DDR-positive. This experiment had the important limitation that the DNA damage site 
could not be visualized in the nucleus. Thus I could not distinguish the specific DDR focus 
generated by the I-SceI endonuclease from the ones caused by the adenoviral infection, 
complicating the interpretation of the experimental results. However, considering a 
background level of DDR, based on the GFP-infected cells, the Telo + I-SceI cells showed 
a slightly higher percentage of DDR-positive cells compared to the I-SceI and Telo cells, 
consistent with our model (Fig. 16b). Similarly, looking at the number of DDR foci per 
cell, both cell lines carrying an I-SceI site showed a similar DDR activation one day after 
the infection, while seven days later, the presence of telomeric repeats induced a more 
persistent DDR compared to the other samples (Fig. 16c). Although the results shown here 
were not dramatic, they are consistent with the hypothesis that accumulation of DNA 
damage at the telomeres might be due to their irreparability. 
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Figure 16. Telomeric repeats close to a double-strand break induce a more persistent DNA damage 
response activation.  
(a) Schematic of the integrated constructs studied in BJ hTERT cells. BJ hTERT cells were electroporated to 
integrate one of the three following constructs: I-SceI, which carries an integrated cut site for the I-SceI 
endonuclease, Telo, a 810 bp of telomeric repeats, and Telo + I-SceI which has an I-SceI site next to the 
telomeric repeats. (b-c) Stable cell lines carrying the indicated constructs were infected with an I-SceI- or 
GFP-expressing adenovirus and immunostained for 53BP1 at the indicated time points post infection. Bar 
graphs show the percentage of 53BP1-positive cells and the number of 53BP1 foci per cell. (For the 
quantification shown, around 40 cells per sample from 1 experiment were analysed; error bars represent 
s.e.m.). 
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4.2 Inhibition of repair at the telomeres is mediated by the telomere-
binding protein TRF2 
4.2.1 Persistent DNA damage at the telomeres is not caused by its heterochromatic state  
Next I tried to investigate the molecular mechanisms at the basis of telomere irreparability. 
Telomeres are made of constitutive heterochromatin (Blasco, 2007) and it has been shown 
that heterochromatic DSBs are generally repaired more slowly than euchromatic DSBs 
(Goodarzi et al., 2008). Thus I tested if persistent DDR at telomeres was related to the 
heterochromatic structure of chromosome ends.  
 
Figure 17. Heterochromatin disruption by VPA treatment does not significantly affect the number of 
persistent DDR foci and their localization at telomeres.  
BJ hTERT cells were treated with the indicated concentration of VPA, irradiated with 20 Gy and analysed 30 
days later. (a) Immunoblot shows the increased levels of acetylated histone H4 (AcH4) in treated cells, 
compared to untreated control. H3 was used as a loading control. (b) Quantification of the number of 53BP1 
foci per cell, in cells treated with the indicated doses compared to untreated control. (For the quantification 
shown, around 100 cells per sample from 1 experiment were analysed; error bars represent s.e.m.). (c) 
Quantification of 53BP1 foci co-localizing with telomeres, in cells treated with the indicated doses compared 
to untreated control. (For the quantification shown, around 30 cells per sample from 1 experiment were 
analysed; error bars represent s.e.m.). 
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I perturbed constitutive heterochromatin treating cells with different concentrations of a 
histone deacetylase inhibitor, valproic acid (VPA) (Marchion et al., 2005). The global 
relaxation of chromatin was monitored by increased acetylation of histone H4 (Fig. 17a). I 
then exposed these and control cells to IRs. Thirty days after irradiation treated cells 
showed no significant difference in terms of number of persistent 53BP1 foci per cell or 
their co-localization with telomeres (Fig. 17b,c), suggesting that VPA treatment could not 
prevent accumulation of persistent DDR foci at the telomeres.  
KAP-1 is a mediator of ATM-dependent DNA repair activity in heterochromatin 
(Goodarzi et al., 2008). I reasoned that, if KAP-1 was necessary for the DNA repair also at 
the telomeres, like in other heterochromatic regions, knock down of this co-factor could 
further increase the accumulation of persistent DDR foci at the telomeres. I exposed stable 
KAP-1 knocked down and control cells (Fig. 18a) to IRs and analyzed them one month 
later. Again no difference was evident in the number of 53BP1 foci per cells or their 
fraction co-localizing with telomeres (Fig. 18b,c). Thus, persistent DDR at telomeres 
cannot be explained as a consequence of their heterochromatic structure. 
 
Figure 18. KAP-1 knock down does not significantly affect the number of persistent DDR foci and 
their localization at telomeres.  
BJ hTERT cells were infected with shGFP or shKAP-1 expressing lentiviruses, irradiated with 20 Gy and 
analysed 30 days later. (a) Immunoblot shows the expression of KAP-1 in shGFP or shKAP-1 BJ hTERT 
cells. Tubulin was used as a loading control. (b) Quantification of the number of 53BP1 foci per cell. (For the 
quantification shown, around 100 cells per sample from 1 experiment were analysed; error bars represent 
s.e.m.). (c) Quantification of 53BP1 foci co-localizing with telomeres. (For the quantification shown, around 
30 cells per sample from 1 experiment were analysed; error bars represent s.e.m.). 
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4.2.2 Persistent DNA damage at the telomeres is not caused by a dramatic TRF2 down-
regulation or mislocalization 
TRF2 is one of the six components of the shelterin complex, which directly binds to 
telomeric DNA (Broccoli et al., 1997). Its loss triggers DDR activation at telomeres and 
chromosomal fusions (d'Adda di Fagagna et al., 2003; Takai et al., 2003; van Steensel et 
al., 1998). Furthermore, during replicative senescence it is down regulated through 
preoteasome-mediated degradation (Fujita et al., 2010). I therefore tested whether 
persistent DDR foci at telomeres were associated with TRF2 loss also during IR-induced 
senescence. The total TRF2 protein level was around 64% in IrrSen cells compared to non-
senescent controls (Fig. 19), a much weaker down-regulation compared to the one reported 
in replicative senescence.  
 
Figure 19. TRF2 expression is not significantly altered in IrrSen cells.  
BJ hTERT and BJ hTERT shp53 cells were irradiated with 20 Gy and analysed 30 days later. (a) 
Immunoblot shows TRF2 and p53 protein levels. Vinculin was used as a loading control. (b) Quantification 
of TRF2 levels in IrrSen cells, compared to non-irradiated cells, normalized on vinculin. 
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Since in replicative senescence TRF2 down-regulation is mediated by p53 and prevented 
by p53 knock down (Fujita et al., 2010), I checked TRF2 protein levels in stable shp53 
cells. Interestingly, I observed the same relative down regulation as in p53 proficient cells. 
One possible explanation for this difference could also partially reflect the increased 
volume of the cytoplasm in senescent cells that can change the cytosolic (vinculin) vs 
nuclear (TRF2) protein ratio. In addition, one copy of the gene is sufficient to protect 
telomeres, and DDR foci at telomeres are evident only upon removal of both alleles (Celli 
and de Lange, 2005). However I wanted to experimentally rule out the possibility that 
DDR accumulation at telomeres was induced by the observed partial TRF2 down-
regulation.  
 
Figure 20. TRF2 over-expression does not significantly affect the number of persistent DDR foci per 
cell and their localization at telomeres.  
BJ hTERT cells were infected with either TRF2 or GFP expressing lentiviruses, irradiated with 20 Gy and 
analysed 30 days later. (a) Immunoblot showing TRF2 expression in TRF2 and GFP over-expressing BJ 
hTERT cells. Vinculin was used as a loading control. Arrow shows endogenous TRF2 in GFP over-
expressing sample. (b) Quantification of the number of 53BP1 foci per cell. (For the quantification shown, 
around 100 cells per sample from 1 experiment were analysed; error bars represent s.e.m.). (c) Quantification 
of 53BP1 foci co-localizing with telomeres. (For the quantification shown, around 50 cells per sample from 1 
experiment were analysed; error bars represent s.e.m.). 
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Thus I over-expressed TRF2 or GFP by lentiviral infection in BJ hTERT cells (Fig. 20a) 
before exposing them to IR. In TRF2 over-expressing cells I could still find persistent 
DDR foci at telomeres, to a similar extent compared to control cells (Fig. 20b,c). 
Most importantly, TRF2 over-expression did not alter the establishment of cellular 
senescence. Indeed 30 days after irradiation, both in non-irradiated and in IrrSen cells, the 
BrdU incorporation rate was not affected at all compared to GFP-expressing cells (Fig. 
21). Similarly, another marker of cellular senescence, the SA-β-gal activity, was detected 
at a very similar level despite TRF2 over-expression (Fig. 22).  
 
Figure 21. Effects of TRF2 over-expression on senescent-associated proliferative arrest.  
TRF2 and GFP over-expressing BJ hTERT cells were irradiated with 20 Gy and analysed 30 days later. (a) 
Representative images of BrdU immunostaining under denaturing condition acquired by widefield 
microscopy. (b) Quantification of BrdU-positive cells in non-irradiated and IrrSen cells. (For the 
quantification shown, around 400 cells per sample from 1 experiment were analysed; error bars represent 
s.e.m.). 
 
Beyond its expression levels, also TRF2 localization at telomere is essential for telomere 
protection (van Steensel et al., 1998). Since TRF2 is recruited at DNA damage sites 
(Bradshaw et al., 2005), one possibility is that upon irradiation TRF2 moves from 
telomeres to the sites of DNA damage, causing deprotection of telomeres. However 
immunoFISH staining of IrrSen cells showed that the vast majority of telomeres, detected 
by a telomeric PNA probe, co-localized with TRF2 (Fig. 23a). Furthermore, around 41% 
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of persistent ATM pS1981 foci, co-localized with TRF2 (Fig. 23b), suggesting that the 
DDR-positive telomeres were not the ones that lost TRF2 protection.  
 
Figure 22. Effects of TRF2 over-expression on senescent-associated beta-galactosidase staining. 
 (a) Representative images of SA-β-gal staining acquired by widefield microscopy. (b) Quantification of SA-
β-gal positive cells, in non-irradiated and IrrSen cells. (For the quantification shown, around 50 cells per 
sample from 1 experiment were analysed; error bars represent s.e.m.). 
 
Figure 23. TRF2 and DDR foci co-localization analysis with telomeric DNA in IrrSen cells.  
Maximum projections of Z-stacks acquired by confocal microscopy show co-localizations between TRF2 
and telomeres, detected using a telomeric PNA probe (Telo) (a) and TRF2 and ATM pS1981 foci (b) in 
IrrSen BJ hTERT cells. The percentage of co-localization (± s.e.m.) is indicated. 
β-gal"DAPI"
GF
P"
TR
F2
"
a." b."
0"
5"
10"
15"
20"
25"
30"
35"
40"
45"
non-irr" IrrSen"
%
 β
-g
al-
po
sit
ive
 ce
lls
"
GFP"
TRF2"
Telo!TRF2! merge + DAPI!
TRF2! merge + DAPI!pATM!
41 ± 7%!
a.!
b.!
 89 
In conclusion, these results strongly indicate that IR-induced senescence and persistent 
DDR at the telomeres are not due to TRF2 loss. 
4.2.3 Ectopic TRF2 localization to a non-telomeric DNA double-strand break is 
sufficient to induce a more prolonged DNA damage response in mouse cells 
Irreparability of telomeric DNA damage could be a feature of telomeric DNA per se or 
could be mediated by the proteins that bind to it. Among the telomere-binding proteins 
TRF2 is a very good candidate for repair inhibition. Indeed it has been previously shown to 
prevent chromosomal fusions in vivo (van Steensel et al., 1998) and to inhibit NHEJ in 
vitro (Bae and Baumann, 2007; Bombarde et al., 2010). To address this issue I took 
advantage of a published cellular system, NIH 2/4 cells (Fig. 24a and (Soutoglou et al., 
2007)).  
 
Figure 24. I-SceI endonuclease can be activated and inactivated in a cellular system.  
(a) Schematic of the integrated locus studied in NIH 2/4 cells. Upon transfection, Cherry-LacI binds to the 
lactose operator (LacO) repeats, YFP-Tet binds to the tetracycline operator (TetO) repeats, and RFP-I-SceI-
GR cuts the specific site between the two sets of repeats. (b) Representative images of γH2AX 
immunostaining and YFP-Tet signal, acquired by confocal imaging. I-SceI ON corresponds to 3 hours after 
RFP-I-SceI-GR induction with triamcinolone acetonide (10 pM), I-SceI OFF corresponds to 24 additional 
hours after removal of inducing agent. 
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They are immortalized mouse fibroblasts, carrying a single integrated cut site for the 
endonuclease I-SceI, flanked by lactose operator repeats on one side and by tetracycline 
operator repeats on the other. This locus could be visualized as a nuclear spot using the 
Cherry-LacI or the YFP-Tet proteins binding to the corresponding array. To validate this 
system I transiently transfected NIH 2/4 cells with an inducible version of I-SceI 
endonuclease, fused to the glucocorticoid receptor (GR), and YFP-Tet constructs. Upon 
addition of the GR ligand triamcinolone acetonide, I-SceI translocated to the nucleus, 
generating a DSB that could be detected by γH2AX focus co-localizing with the YFP-Tet 
signal (I-SceI ON). After removal of TA, I-SceI was again restricted to the cytoplasm, 
allowing the cells to repair the DSB (I-SceI OFF). This could be monitored by the 
disappearance of the γH2AX focus (Fig. 24b). I used the Cherry-LacI plasmid to generate 
the LacI construct, then I added a truncated TRF2 CDS, lacking its DNA binding domain, 
to generate the LacI-TRF2 construct. The two proteins were over-expressed upon transient 
transfection in NIH 2/4 cells (Fig. 25a) and importantly they both co-localized with YFP-
Tet protein at the I-SceI site (Fig 25b).  
 
Figure 25. LacI and LacI-TRF2 proteins localization at the I-SceI locus.  
NIH 2/4 cells were transfected with YFP-Tet and either LacI or LacI-TRF2 expressing plasmids. (a) 
Immunoblot with anti-LacI and TRF2 antibodies shows LacI and LacI-TRF2 over-expression. (b) 
Representative images of LacI immunostaining and YFP-Tet signal, acquired with confocal microscope. 
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The expression of LacI-TRF2 enabled the accumulation of TRF2 next to an exposed non-
telomeric DNA end, which resembled a telomere bearing telomeric proteins but lacking 
telomeric DNA. After I-SceI activation a local DDR was triggered, as shown by γH2AX 
focus formation co-localizing with YFP-Tet signal. Following I-SceI inactivation, in cells 
expressing LacI alone, the percentage of DDR-positive cells at the locus studied was 
significantly reduced from 65% to 22%. Differently, in LacI-TRF2-expressing cells, DDR 
focus persisted in a significantly larger fraction of cells when compared with the LacI 
control (40% vs 22%, respectively; Fig. 26). This strongly suggested that TRF2 is 
sufficient to induce a more protracted DDR at a non-telomeric DSB.  
 
Figure 26. Ectopic TRF2 modulates DDR focus persistence at a non-telomeric DSB.  
NIH 2/4 cells were transfected with RFP-I-SceI-GR, YFP-Tet and either LacI or LacI-TRF2 expressing 
plasmids. Quantification of cells positive for γH2AX at the I-SceI locus expressing LacI or LacI-TRF2, as 
detected by immunostaining and confocal microscopy. I-SceI site was detected as a distinct focus double-
positive for YFP-Tet and anti-LacI antibody signals (* p value < 0.05, calculated by chi square test; for the 
quantification shown, around 100 cells per sample were analysed; n = 3 independent experiments; error bars 
represent s.e.m.). 
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over-expressed (Fig. 27a) and co-localized with the anti-LacI signal at the I-SceI site (Fig 
27b).  
 
Figure 27. YFP-Tet-TRF2 protein localization at the I-SceI locus.  
NIH 2/4 cells were transfected with LacI and either YFP-Tet or YFP-Tet-TRF2 expressing plasmids. (a) 
Immunoblot with anti-GFP and TRF2 antibodies shows YFP-Tet and YFP-Tet-TRF2 over-expression. (b) 
Representative images of LacI immunostaining and YFP signal, acquired with confocal microscope. 
 
Unexpectedly, after I-SceI cut, the targeting of TRF2 at both DNA ends reduced the 
fraction of DDR-positive cells, compared to control cells. Nonetheless, 24 hours after I-
SceI inactivation, TRF2 over-expressing cells retained the DDR focus in a higher fraction 
(Fig. 28). I could speculate that the presence of TRF2 at both sides of the I-SceI locus 
interfered with the I-SceI cut, because of steric hindrance, slowing down the cut kinetics. 
At later time points (I-SceI OFF), this effect was no more evident, leading to the expected 
more protracted DDR activation mediated by TRF2. The transient nature of the experiment 
did not allow me to further extend the studied time points, so I decided to target TRF2 to 
only one side of the DSB for the following experiments. Indeed in in vitro experiments it 
has been shown that the telomeric repeats inhibit NHEJ only in 5’ to 3’ direction (Bae and 
Baumann, 2007), making unnecessary the coating of both ends with TRF2. 
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Figure 28. Ectopic TRF2 localization on both sides of DSB is inducing a more persistent DDR 
activation.  
NIH 2/4 cells were transfected with RFP-I-SceI-GR, LacI and either YFP-Tet or YFP-Tet-TRF2 expressing 
plasmids. Quantification of cells positive for γH2AX at the I-SceI locus, as detected by immunostaining and 
confocal microscopy. I-SceI site was detected as a distinct focus double-positive for YFP and anti-LacI 
antibody signals (* p value < 0.05, calculated by chi square test; for the quantification shown, around 50 cells 
per sample were analysed; n = 2 independent experiments; error bars represent s.e.m.). 
4.2.4 DDR focus persistence mediated by TRF2 is specific and it acts in cis only 
The LacI protein is smaller than the fusion product LacI-TRF2 (39 kDa vs 84 kDa), thus 
one possibility is that TRF2 is inhibiting the repair activity of the cell by steric hindrance.  
 
Figure 29. LacI-TRF1 protein localization at the I-SceI locus.  
NIH 2/4 cells were transfected with YFP-Tet and either LacI or LacI-TRF1 expressing plasmids. (a) 
Immunoblot with anti-LacI antibody shows LacI and LacI-TRF1 over-expression. (b) Representative images 
of LacI immunostaining and YFP signal, acquired with confocal microscope. 
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To exclude this I repeated the experiment using different constructs, the LacI fused to 
Cyan Fluorescent Protein (Soutoglou et al., 2007) (CFP-LacI, 66 kDa) or to another 
telomere binding protein, TRF1 (LacI-TRF1, 84 kDa). I generated this fusion protein using 
the LacI construct and the truncated TRF1 CDS, lacking its DNA binding domain, and I 
checked the expression and the localization to I-SceI site of the LacI-TRF1 protein in NIH 
2/4 cells (Fig. 29).  
 
Figure 30. TRF2 effect on I-SceI site is specific and not due to steric hindrance.  
NIH 2/4 cells were transfected with RFP-I-SceI-GP, YFP-Tet and either LacI, LacI-CFP, LacI-TRF1 or 
LacI-TRF2 expressing plasmids. (a) Quantification of cells positive for γH2AX at the I-SceI locus expressing 
LacI, LacI-CFP or LacI-TRF2, as detected by immunofluorescence and confocal microscopy. (* p value < 
0.05, calculated by chi square test; for the quantification shown, around 30 cells per sample from 1 
experiment were analysed; error bars represent s.e.m.). (b) Quantification of cells positive for γH2AX at the 
I-SceI locus expressing LacI, LacI-TRF1 or LacI-TRF2, as detected by immunofluorescence and confocal 
microscopy. (* p value < 0.05, calculated by chi square test; for the quantification shown, around 60 cells per 
sample were analyzed; n = 2 independent experiments; error bars represent s.e.m.). 
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Then I studied the DDR focus formation and disappearance in cells expressing either LacI, 
LacI-CFP, LacI-TRF1 or LacI-TRF2 proteins. Again, the presence of TRF2 induced a 
more persistent γH2AX focus compared to all the other controls (Fig. 30), suggesting that 
its action is specific and not due to steric hindrance. Furthermore, the ability to induce a 
more persistent DDR focus at a DSB site seems to be limited to the TRF2 protein only as 
TRF1, another component of the shelterin complex, did not behave differently from the 
LacI control. Next I investigated whether the increased persistency of the DDR focus at the 
I-SceI site was due to an impact of TRF2 over-expression on the global DDR activation of 
the cell.  
 
Figure 31. TRF2 acts in modulating DDR focus persistence only in cis.  
NIH 2/4 cells were transfected with YFP-Tet and either LacI or LacI-TRF2 expressing plasmids, irradiated (2 
Gy) 24 hours later and analysed at the indicated time points following irradiation. (a) Representative images 
of γH2AX and LacI immunostaining and YFP signal acquired by widefield microscopy at the indicated time 
points after irradiation. (b) Quantification of the number of γH2AX foci per cell. (For the quantification 
shown, around 30 cells per sample from 1 experiment were analysed; error bars represent s.e.m.). 
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Cells over-expressing LacI or LacI-TRF2 were irradiated to generate DNA damage 
randomly in the genome. The DDR foci resolution kinetics was not affected by TRF2 over-
expression (Fig. 31), showing that TRF2 acts locally in cis only. 
4.2.5 TRF2 inhibits physical double-strand break repair 
The more persistent site-specific γH2AX focus induced by TRF2 indicates that the DDR 
machinery is switched off less efficiently, but it did not give any information about the 
repair of the DSB. To address this point, I adapted a protocol for BrdU staining under non-
denaturing conditions to my experimental setup. This protocol was initially optimized for 
detection of single-stranded DNA during replicative stress (Ye et al., 2010). When I-SceI 
generated a site-specific DSB, as monitored by γH2AX focus formation, a co-localizing 
BrdU punctuated signal is detectable because of the exposed DNA ends. After I-SceI 
inactivation, the repair activity of the cell re-joined the two DNA ends, so the BrdU signal 
could not be detected anymore (Fig. 32a). In NIH 2/4 cells over-expressing LacI or LacI-
TRF2, the generation and repair of physical DNA damage, monitored by BrdU signal, 
mirrors the DDR-focus formation, (Fig. 32b). This strongly suggests that TRF2 is 
sufficient to inhibit not only the DDR focus disappearance, but also the DNA repair of 
DSBs, providing a mechanism for irreparability of telomeric DNA damage. This result 
further supports the in vivo evidence in Saccharomyces cerevisiae, showing that Rap1, 
which directly bind telomeric DNA in budding yeast, is required for NHEJ inhibition at 
telomeres (Marcand et al., 2008). 
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Figure 32. Ectopic TRF2 modulates DNA repair at a non-telomeric DSB.  
NIH 2/4 cells were transfected with RFP-I-SceI-GP, YFP-Tet and either Cherry-LacI, LacI or LacI-TRF2 
expressing plasmids and were incubated with BrdU (10µg/ml) for 16 hours. (a) Representative images of 
LacI, γH2AX and BrdU immunostaining under non-denaturing conditions, acquired by confocal microscopy. 
(b) Quantification of cells expressing LacI or LacI-TRF2 positive for BrdU signal at the I-SceI-locus, as 
detected by immunostaining and confocal microscopy. Values were normalized on the fraction of cells that 
had incorporated BrdU. (* p value < 0.05, calculated by chi square test; for the quantification shown, around 
100 cells per sample were analysed; n = 2 independent experiments; error bars represent s.e.m.).  
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4.3 Persistent DNA damage accumulates at the telomeres, also in a non-
proliferating tissue of aged primates 
The results shown about the irreparability of telomeric DNA damage can be relevant also 
for the ageing field. Indeed it has been shown that ageing primates accumulate DDR foci 
co-localizing with telomeres in vivo (Herbig et al., 2006; Jeyapalan et al., 2007; Nijnik et 
al., 2007; Rossi et al., 2007). This observations have been made only in proliferating 
tissues such as dermal fibroblasts, stem cells and progenitors, so it was unclear whether 
such DDR was triggered solely by telomere shortening. I therefore decided to extend these 
observations studying the accumulation of endogenous DNA damage in vivo, in aged 
baboons. I analysed hippocampus, which is made of non-proliferating, terminally 
differentiated neurons, so they are not expected to undergo progressive telomere attrition. I 
performed a staining for the DDR marker 53BP1 of hippocampal samples from young and 
old baboons. I observed that a higher fraction of cells stained positive for 53BP1 in old 
samples compared to the young ones, confirming that also in non-proliferating tissues 
endogenous DNA damage could accumulate during ageing (Fig. 33).  
 
Figure 33. DDR activation in hippocampus of primates during ageing.  
Quantification of 53BP1 foci-positive cells in hippocampal neurons of 4 old baboons, compared to 2 young 
ones (* p-value < 0.05, calculated by chi square test; error bars represent s.e.m.). 
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Then I also looked at the co-localization between 53BP1 foci and telomeres in the old 
baboons (Fig. 34a). The use of PNA probe in immunoFISH experiments generated discrete 
signals amenable for quantization, as the fluorescence intensity of the spots was directly 
correlated to the length of the telomeres. So I could plot the distribution of total telomeres 
accordingly to their length and compare it to the length of DDR-positive telomeres. 53BP1 
foci did not co-localized preferentially with the critically short telomeres (Fig. 34b), 
consistently with the hypothesis that DNA damage is accumulating at the telomeres 
because they are irreparable and not because of their shortening. 
 
 
Figure 34. DDR-positive telomeres in hippocampus of aged primates are not the critically short 
telomeres.  
(a) Maximum projections of Z-stacks acquired by confocal microscopy show 53BP1 foci and telomeres, 
detected using a telomeric PNA probe (Telo) in hippocampal neurons of aged baboons. (b) Relative 
distribution of total telomere lengths (upper histogram) and of 53BP1-focus-positive telomere lengths (lower 
histogram), according to telomeric probe signal intensity (Telomere Fluorescence Arbitrary Units) in 
hippocampal neurons from aged baboons. (Telomeres from 4 individual baboons were analysed). 
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4.4 DDRNA are necessary for DNA damage activation and maintenance 
at uncapped telomeres 
4.4.1 Telomere induced foci are RNA-dependent 
A report published by our group described an unexpected link between the DDR and 
components of the RNAi machinery. Indeed we characterized a new class of 21-22 
nucleotides-long DICER and DROSHA RNA products in mammalian cells. These short 
RNAs (named DNA damage response RNAs or DDRNAs) have the sequence of the 
damaged locus and are necessary for DDR activation and maintenance specifically at that 
locus (Francia et al., 2012). Short RNAs with a similar biogenesis have been observed and 
tentatively implicated in DNA repair also in other model systems like Arabidopsis 
Thaliana (diRNAs (Wei et al., 2012)) and Drosophila (endo-siRNAs (Michalik et al., 
2012)). Telomeres are the ends of linear chromosomes, but they are not recognized by the 
cellular DDR machine as DSBs because they are protected by the shelterin component 
TRF2 (de Lange, 2005). Removal of this protection makes the telomeres to be not 
distinguishable from normal DSBs and causes DDR activation specifically at the 
telomeres. This may lead to cellular senescence, chromosomal fusions and genome 
instability (Sfeir and de Lange, 2012). Since nothing was known about the role of 
DDRNAs at deprotected, DDR-positive telomeres, I decided to explore the potential role 
of DDRNAs at dysfunctional telomeres. For this purpose, I used CRE-ER TRF2flox/flox 
MEFs (Celli and de Lange, 2005). Cells were grown in presence of 4-hydroxytamoxifen 
for 48 hours to induce CRE recombinase localization into the nucleus, thus generating a 
TRF2-knockout (TRF2-/-) cell line. TRF2 removal promptly induced telomere induced foci 
(TIFs) (Fig. 35 and (Celli and de Lange, 2005)).  
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Figure 35. TRF2-/- MEFs show DDR activation at telomeres.  
MEFs CRE-ER TRF2flox/flox cells were treated with 4-hydroxytamoxifen (0.6 µM) for 48 hours to induce 
TRF2 knock out. Representative images, acquired by confocal microscope, show co-localization of 53BP1 
and telomeres, detected using a telomeric PNA probe (Telo). 
 
I then permeabilized living MEFs TRF2-/- with a mild detergent and treated them with 
RNase A or BSA as a control. Consistent with our previous results (Francia et al., 2012), I 
observed that γH2AX foci were not affected, while 53BP1 foci were sensitive to RNase A 
treatment (Fig. 36). Thus, like other DSB lesions, also at uncapped telomeres RNA is 
necessary for the maintenance of 53BP1 foci. Next, I tested whether DDR foci could be 
allowed to reform in RNase A-treated cells by adding back RNA. For this purpose I 
extracted total cellular RNA using a specific kit in order to retain also short RNAs. 
Telomere-uncapped cells were treated with RNase A, and incubated in the presence of α-
amanitin, an inhibitor of RNA Polymerase II, to block transcription, which would allow 
spontaneous transcription and focus reformation (Francia et al., 2012). I added RNA 
coming from TRF2-/- MEFs, and yeast tRNA as a control. Interestingly, only cellular RNA 
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coming from damaged cells could partially rescue 53BP1 foci after RNase A treatment 
(Fig. 37). 
 
 
Figure 36. RNase A treatment impairs 53BP1 localization at uncapped telomeres.  
TRF2-/- MEFs cells were permeabilized and treated with BSA or RNase. (a) Representative images, acquired 
by widefield microscope, show that γH2AX foci are stable, while 53BP1 foci disassemble upon RNase A 
treatment. (b) Quantification of γH2AX and 53BP1 foci in RNase A and BSA treated cells. (*** p value < 
0.001, calculated by chi square test; for the quantification shown, around 150 cells per sample were analysed; 
n = 2 independent experiments; error bars represent s.e.m.). 
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Figure 37. Total cellular RNA can rescue DDR foci at telomeres in RNase A treated cells.  
TRF2-/- MEFs cells were permeabilized and treated with BSA or RNase A. RNase A treated cells were 
incubated with yeast tRNA and RNA coming from TRF2-/- MEFs, in the presence of α-amanitin. Bar graph 
shows the quantification of γH2AX and 53BP1-positive cells. (** p value < 0.01, *** p value < 0.001, 
calculated by chi square test; for the quantification shown, around 150 cells per sample were analysed; n = 2 
independent experiments; error bars represent s.e.m.) 
 
4.4.2 Telomere induced foci are DICER and DROSHA-dependent 
Next I investigated the role of DICER and DROSHA on DDR activation at dysfunctional 
telomeres. I transiently knocked down DICER or DROSHA in MEFs TRF2-/- (Fig. 38a) 
and looked at the TIFs formation. Consistent with the published results (Francia et al., 
2012), γH2AX foci were not affected by DICER or DROSHA knock down (Fig. 38b,d). 
Differently from what observed in IR-induced DNA damage (Francia et al., 2012), also 
53BP1 was not affected (Fig. 38b,d). However, this apparent inconsistency can be 
explained by the fact that 53BP1 needs DDRNAs for the localization at the DNA damage 
site only initially after the DNA damage generation, but it gets eventually recruited in a 
DDRNA-independent manner (Francia et al., 2012). Since the DNA damage at unprotected 
telomeres is not acute as studied by Francia et al, but persistent, at the time of the analysis, 
53BP1 was expected to localize at the damaged loci.  
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Figure 38. DICER and DROSHA knock down impairs DDR foci formation at uncapped telomeres.  
TRF2-/- MEFs were transiently transfected with siDICER, siDROSHA or siGFP as a control. (a) Triplicate 
qPCR reactions with Sybr Green chemistry show the knock down levels of DICER and DROSHA. (b-c) 
Representative images of γH2AX, 53BP1, ATM pS1981, pS/TQ foci, acquired by widefield microscope. (d) 
Quantification of the fraction of DDR-positive cells. (** p value < 0.01, *** p value < 0.001 calculated by 
chi square test; for the quantification shown, around 150 cells per sample were analysed; n = 2 independent 
experiments; error bars represent s.e.m.). 
Then I extended this observation to other DDR markers; in particular I studied foci 
containing ATM pS1981, and proteins phosphorylated by ATM or ATR (pS/TQ). While 
discrete foci were detected in the control cells, upon DICER and DHOSHA knock down, 
DDR focal signals were reduced or became diffused in the nucleus (Fig. 38c,d). Thus, 
differently from γH2AX and 53BP1, the recruitment to the unprotected telomeres of ATM 
and its downstream targets needs DICER and DROSHA. 
4.4.3 Chromosomal fusions in TRF2-deficient cells are DICER and DROSHA-dependent 
In Arabidopsis thaliana diRNAs are necessary for efficient repair by HR (Wei et al., 
2012). Chromosomal fusions are repair events mediated mainly by NHEJ (Sfeir and de 
Lange, 2012) so I asked whether DDRNAs have a role also in this repair pathway. I 
transiently knocked down DICER or DROSHA in MEFs TRF2-/- cells and analyzed 
metaphase spreads after colcemid block. Control cells showed massive chromosomal 
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fusions, as already shown in (Celli and de Lange, 2005). In contrast, both DICER and 
DROSHA knocked down cells showed a lower degree of fusions (Fig. 39), indicating that 
DICER and DROSHA are involved also in NHEJ pathway.  
 
Figure 39. DICER and DROSHA knock down impairs chromosomal fusions.  
TRF2-/- MEFs were transiently transfected with siDICER, siDROSHA or siGFP as a control. (a) 
Representative images of metaphase spreads acquired by widefield microscope. (b) Dot plot shows the 
number of fused chromosomes per metaphase spread, solid line indicate the median value. (For the 
quantification shown, 10 metaphase spreads for each condition from 1 experiment were analysed). 
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4.4.4 Inhibition of DDRNAs function can revert the senescence phenotype 
Cells can accumulate damaged telomeres during ageing, due to telomeric shortening 
(d'Adda di Fagagna et al., 2003; Harley et al., 1990; Herbig et al., 2004) or to endogenous 
or exogenous DNA damage occurred at telomeres because they are not repairable (see 
chapter 4.3). In both cases this persistent DDR activation at telomeres leads to cellular 
senescence. Based on the preliminary results about the role of RNA, DICER and 
DROSHA in DDR foci formation and maintenance at dysfunctional telomeres, I 
hypothesized that DDRNAs with telomeric sequence are generated locally to sustain DDR. 
Inhibiting their action could suppress DDR activation at the telomeres and potentially 
prevent or revert the senescence phenotype. To test this, I used a human cell line, T19 
fibrosarcoma cells that express an inducible dominant negative (DN) allele of FLAG-
tagged TRF2 (van Steensel et al., 1998). The expression of this allele was induced 
culturing cells in the absence of doxycycline. After 7-8 days of induction, cells expressing 
the DN TRF2 allele stained positive for FLAG-tag and DNA damage response in the form 
of 53BP1 foci and they acquired a senescence phenotype (Fig. 40a and (van Steensel et al., 
1998)). Most of these DDR foci co-localized with the telomeric PNA probe, indicating that 
they were caused by telomere uncapping (Fig. 40b and (van Steensel et al., 1998)). To 
reach a strong and specific inhibition of telomeric DDRNAs, I chose LNAs antisense 
oligonucleotides. They are modified ribonucleotides with an extra bridge connecting the 2' 
oxygen and 4' carbon of the sugar that confers higher stability and specificity to the 
molecule (Jepsen et al., 2004). LNAs have been already used to inhibit miRNAs also in 
vivo (Machlin et al., 2012; Naguibneva et al., 2006; Obad et al., 2011). I used two different 
LNA inhibitors, one containing few copies of the 5’-TTAGGG-3’ repeat (Telo G) and one 
with the complementary sequence (Telo C), that should in principle bind and inhibit 
DDRNAs transcribed from the G- and C-rich telomeric strand, respectively. After 
induction of DN TRF2 expression, I transfected T19 cells with Telo G and Telo C LNA 
molecules and a control LNA with an unrelated sequence (Cntr).  
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Figure 40. Dominant negative TRF2 expression induces DDR activation at telomeres in T19 cells.  
The expression of a dominant negative allele of FLAG-tagged TRF2 was induced by removal of doxycycline 
from the culturing medium in T19 cells. (a) Representative images of FLAG and 53BP1 immunostaining 
acquired by widefield microscope. (b) Representative images of FLAG and 53BP1 immunostaining and 
telomere signal, detected using a telomeric PNA probe (Telo), acquired by confocal microscope. 
 
I observed that, with time, in cells expressing DN TRF2 (FLAG +), both telomeric LNAs 
transfected individually decreased the percentage of 53BP1-positive cells, to a different 
extent, while control LNA had no effect (Fig. 41). Importantly, in non-induced, 
undamaged cells (FLAG -) LNA molecules did not induce any DNA damage, excluding 
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that they could be toxic per se. Since a constant DDR activation is necessary for 
senescence maintenance ((d'Adda di Fagagna et al., 2003; Herbig et al., 2004; Sedelnikova 
et al., 2004; von Zglinicki et al., 2005) and chapter 4.1.2)  
 
Figure 41. LNA transfection has an impact on DDR in telomere-uncapped cells.  
T19 cells were induced by doxycyclin removal and transfected with LNA molecules (200 nM) matching the 
telomeric G- or C-rich strand (Telo G and C, respectively) and an unrelated control sequence (Cntl). 53BP1 
foci-positive cells were scored at the indicated time points post transfection, in telomere-uncapped cells 
(FLAG +) or uninduced (FLAG -) cells. (For the quantifications shown, around 30-100 cells for each time 
point from 1 experiment were analysed; error bars represent s.e.m.). 
 
Figure 42. LNA transfection promotes cell cycle progression of senescent cells.  
T19 cells were induced by doxycyclin removal and transfected with LNA molecules (200 nM) matching the 
telomeric G- or C-rich strand (Telo G and C, respectively) and an unrelated control sequence (Cntl). Bar 
graph shows BrdU incorporation rate after 16 hours of BrdU incubation. (* p value < 0.05, *** p value < 
0.001, calculated by chi square test; for the quantification shown, around 150 cells per sample were analysed; 
n = 3 independent experiments; error bars represent s.e.m.). 
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I reasoned that inhibiting DDR activation with LNA molecules could be sufficient to 
prevent the proliferation arrest that occurs at senescence. I thus analyzed the passage 
through the S phase of cell cycle, by monitoring BrdU incorporation in induced T19 cells 
after LNA transfection. I observed that cells transfected with both telomeric LNAs, 
proliferated significantly more than control cells (Fig. 42), suggesting that LNA, by 
inactivating DDR at telomeres, can promote cell cycle re-entry. 
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5 Discussion 
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5.1 Persistent DDR activation at telomeres is the trigger for cellular 
senescence establishment and maintenance 
5.1.1 IR-induced senescence is maintained by a persistent DDR 
Replicative senescence is triggered and maintained by DDR, and impairment of DDR 
factors results in cell cycle re-entry and senescence escape (d'Adda di Fagagna et al., 2003; 
Herbig et al., 2004; Sedelnikova et al., 2004; von Zglinicki et al., 2005). This conclusion 
has been a matter of debate, because it has also been reported that activation of the DDR 
might represent an early and initial step in the process of cellular senescence activation, 
which is later on inactivated once senescence is fully established (Bakkenist et al., 2004; 
Chen and Ozanne, 2006). Additional unpublished data from our group show that DDR 
signalling in the form of nuclear foci are instead very stable in senescent cells and can be 
detected in two independent batches of senescent human skin fibroblasts, even 3 years 
after they had stopped proliferating. These fibroblasts have been previously demonstrated 
to undergo telomere-initiated cellular senescence (Mondello et al., 2003). This data suggest 
that, at least in some conditions, DDR can indefinitely be maintained. Furthermore, I 
showed that impairment of DDR cascade by ATM inhibition caused the escape from cell 
cycle arrest in IrrSen BJ hTERT cells (Figs. 6-8), indicating that senescence status is 
maintained by a constantly active DDR signalling. The differences observed might derive 
by a differential response to senescence establishment that can be cell type specific. 
Indeed, by irradiating in parallel BJ, WI-38 and IMR-90 human fibroblasts, I could 
observe a reduction of DDR foci with time in IMR-90 only (Fig. 10) but, importantly, this 
was also associated with considerable cell death (Fig. 11). One explanation could be that 
IMR-90 cells are more sensitive to standard cell culture conditions and are prone to die by 
culture shock due to oxidative stress or excessive mitogenic stimuli. Indeed, even in the 
absence of irradiation, a significant fraction of these cells died after one month in culture, 
and this effect was exacerbated upon DNA damage generation. However, further 
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experiments are needed to identify and characterize the mechanisms that explain the 
reduction of the cell number in a population of senescent cells.  
Based on these observations, I can anticipate that, when senescence is a stable condition, it 
is normally associated with a permanent DDR signalling; if a senescent population is not 
stable and is characterized by cell death, then a decrease in the number of DDR-positive 
cells will be observed. 
5.1.2 Quality, not quantity, distinguish persistent from transient DNA damage response 
The dose of DNA damage used to induce cellular senescence may be considered higher 
than the levels organisms could normally experience all at once. It thus could be argued 
that the observed phenotype is the outcome of an artificial system, irrelevant for in vivo 
situations. Nevertheless, I observed a comparable amount of persistent DDR foci even 
fractionating the same dose over 10 days (Fig. 5), indicating that the observed effect is not 
ascribable to saturation of cellular DNA repair machinery that cannot cope with an acute 
relatively high amount of DNA damage. Consistently, persistent DDR foci were induced 
also by a lower dose of irradiation, although to a lower extent (Fig. 5). This model nicely 
fits with the hypothesis that DNA damage is randomly generated in the genome and the 
rupture of telomeric DNA, responsible for the focus persistency, is a stochastic event. Thus 
it is more likely to occur as the initial amount of DNA damage increases. Doing some 
simple calculations can be informative. I observed that, at the time of senescence 
establishment, around 5-8 foci were detectable per cell, and around 1 out of 3-4 of them 
were at telomeres (Fig 13). This means that, on average, each cell has 1.5-2 TIFs, so most 
of the cells had at least one TIF, which can trigger senescence. A lower amount of DNA 
damage would instead induce persistent DDR and senescence in a minor fraction of cells, 
while all the others that did not receive a telomeric DNA damage would keep proliferating 
and eventually take over the culture. Thus the need to use a relatively high level of IR to 
experimentally induce cellular senescence in the bulk population of cells is dictated by the 
chance to hit at least a telomere in each cell. 
 114
The number of persistent DDR foci observed in IrrSen cells is relatively low (Fig. 4), and 
quite similar to the number observed upon a low dose of irradiation. In addition, IrrSen 
cells retain the ability to repair additional DNA damage if exposed again to IR (Fumagalli 
et al., 2012). This suggests that, in the same cell, both transient and persistent DDR foci 
co-exist and the few persistent DDR foci have some peculiarity that distinguish them from 
all the other DSBs. The persistent DDR foci have many similarities with the transient ones. 
They share many components of the DDR machinery such as γH2AX, 53BP1, pATM, and 
pS/TQ. However, some differences in the downstream DDR signalling pathway can be 
conceived as possible, which may discriminate between promptly repaired lesions and 
those that will instead stimulate a more protracted DDR and therefore cellular senescence 
establishment. Indeed, I found that the downstream kinase CHK2, which is phosphorylated 
by ATM upon DSB generation, was detected at the persistent DNA damage sites in the 
form of discrete nuclear foci, differently from what is commonly observed at early time 
points after irradiation (Fig. 9 and (Lukas et al., 2003)). Thus, differently from repairable 
DNA damage that is promptly fixed, persistent DDR foci retain also some downstream 
factors, that normally diffuse into the nucleus. It has recently been shown that 
dysfunctional telomeres elicit a peculiar DDR, in which ATM is activated, but no ATM-
dependent CHK2 phosphorylation at threonine 68 is detectable by immunoblot (Cesare et 
al., 2013). However, this technique may not be sensitive enough to detect local low 
accumulation of CHK2, visualized by immunofluorescence. My interpretation is that, upon 
telomeric DNA damage, ATM phosphorylates CHK2, but the DDR cascade is somehow 
interrupted at this level. CHK2 is thus retained at the DNA damage site and cannot be fully 
activated and thus spread the DDR signalling throughout the nucleus. It would be 
interesting studying the autophosphorylation site of CHK2 that has been shown to be 
necessary for its full activation following DNA damage (Wu and Chen, 2003). 
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5.1.3 Telomeric DNA damage triggers cell cycle arrest and cellular senescence 
The observation that, with time, persistent DDR co-localize preferentially with telomeres 
both in vitro and in vivo (Figs. 13,14), and that a single DSB specifically generated within 
telomeric repeats induces a more persistent DDR activation (Fig. 16), strongly suggest that 
telomeres are genomic location that resist repair. This model is further supported by other 
published results from our group confirming DDR markers accumulation at subtelomeric 
regions by different approaches, such as ChIP-qPCR and ChIP-seq (Fumagalli et al., 
2012). In addition, another group independently reached the same conclusions using a very 
similar experimental setup (Hewitt et al., 2012). 
This model might seem in contrast with previously published works, where authors 
showed that, in Saccaromices cerevisiae, a telomeric DSB induces an anticheckpoint 
(Michelson et al., 2005; Ribeyre and Shore, 2012). One reason could be the difference in 
the model system used – yeast vs mammals. While in single-cell organism a damaged 
telomere could be tolerated as the only option for survival, in a complex multicellular 
organism, telomeric dysfunction can lead to genomic instability and cancer. Importantly 
however, these studies only focused on the G2/M checkpoint, showing that a damaged 
telomere do not promote arrest in G2/M, differently from a non-telomeric DSB (Michelson 
et al., 2005; Ribeyre and Shore, 2012). In most experiments that I performed, cells were 
arrested in G0 prior to DNA damage induction, and never re-entered the cell cycle upon 
release from contact inhibition, as monitored by a virtually absent BrdU incorporation, 
unless upon impairment of DDR activation (Fig. 7). The experimental evidence that I 
described suggests that a damaged telomere induces a G1/S checkpoint that impedes the 
cell cycle re-entry and induces a stable G1 senescence condition. This is consistent with a 
recent report showing that DDR-positive telomeres do not induce the G2/M checkpoint 
(Cesare et al., 2013). Despite DDR activation, cells progress through the cell cycle and 
arrest in a stable diploid G1 condition, when a p53-dependent cell cycle arrest is activated.   
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5.2 TRF2 as an inhibitor of DNA repair at telomeres 
5.2.1 Persistent DDR at telomeres is mediated by the telomere-binding protein TRF2 
The observed impaired or slower repair kinetics at the telomeres could in principle be 
explained by different mechanisms. Telomeres and subtelomeres show heterochromatic 
markers, like histones and DNA methylation (Blasco, 2007), making them potentially 
difficult to repair (Goodarzi et al., 2008). Nonetheless, neither global chromatin relaxation 
nor knock down of KAP-1, an important factor for repair in heterochromatin, have an 
impact on DDR foci persistency at telomeres (Figs. 17,18), indicating that the telomeric 
DNA per se may not be sufficient to explain the observed phenotype. 
Shifting my attention from telomeric DNA to the telomere-binding proteins, I tested the 
role of TRF2 on DDR focus persistency. I ectopically targeted it to a non-telomeric DSB in 
order to exclude any potential impact of the telomeric DNA. The observed impaired DDR 
focus resolution in the presence of TRF2 (Fig. 26) strongly indicates that telomere 
irreparability is, at least in part, mediated by the proteins that bind to it, such as TRF2 and 
its associated factors. The observation that in IrrSen cells TRF2 was partially down 
regulated (Fig. 19) has two important implications. It is known that over-expression of 
TRF2 leads to a decrease in heterochromatin marks at telomeres (Benetti et al., 2008b), 
suggesting the idea that a down-regulation could have the opposite effect. The second 
scenario is based on the three-state model of telomeres proposed by Reddel and 
Karlseder’s groups (Cesare et al., 2013; Cesare et al., 2009). According to this model, 
telomeres can be in three different conditions. In the presence of normal levels of TRF2, 
telomeres are in the closed or fully capped state, which protects telomeres from both DDR 
activation and chromosomal fusions. If TRF2 levels at telomeres decrease, because of 
experimental knock down or during replicative senescence, when telomeric DNA become 
shorter and can bind to a lower amount of proteins, telomeres are in the intermediate state, 
they can still resist repair, but activate the DDR. Finally, a complete TRF2 loss, such as the 
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one achieved by knock out of both alleles, leads to the uncapped state, when the telomere 
is also prone to fusions. 
Based on the evidences reported above, the partial down-regulation of TRF2 in IrrSen cells 
can contribute to persistent DDR foci at telomeres through two independent mechanisms; 
by increasing heterochromatin, thus making telomeres harder to repair, or by promoting 
the intermediate state of telomeres, a structure that activate the DDR. Both these 
mechanisms however can be excluded, because TRF2 over-expression prior to DNA 
damage induction did not prevent the DDR foci accumulation at telomeres as well as 
senescence establishment (Figs. 20-22), revealing that TRF2 is acting in a different way. 
5.2.2 TRF2 induces a persistent DDR activation at damaged telomeres while inhibiting 
DNA repair  
Normally telomeres are not recognized as DSBs because TRF2 has been proposed to 
suppress DDR activation through ATM inhibition. Two possible models can be 
anticipated; the first one is a direct inhibition of ATM activation by TRF2. This hypothesis 
is based on the observation that TRF2 and ATM physically interact in vivo, and TRF2 
over-expression reduces ATM phosphorylation and G2/M checkpoint upon IR (Karlseder 
et al., 2004). However, in this report, nothing was shown regarding the G1/S checkpoint, 
which is the one most likely activated in senescent cells. In addition, the effect on the DDR 
activation induced by irradiation can be explained by a differential role of TRF2 at non-
telomeric DSBs. Indeed TRF2 has been reported to transiently localize to DSB sites 
(Bradshaw et al., 2005). The results that I have shown seem to exclude a direct local 
inhibition of DDR, since TRF2-coated non-telomeric DSBs elicited a more protracted 
γH2AX focus (Fig 26) and TRF2 over-expression did not significantly impair persistent 
DDR foci accumulation at telomeres and consequent senescence establishment (Fig. 20). 
More direct evidence is the high extent of recruitment of pATM at TRF2-positive 
telomeres in IrrSen cells (Fig. 23b), indicating that the presence of TRF2 is not impeding 
ATM activation at telomeres.  
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A possible explanation that can reconcile these only apparently opposite conclusions 
comes from experimental results showing that in vitro TRF2 can inhibit NHEJ repair only 
in 5’ to 3’ direction (Bae and Baumann, 2007). In addition in vivo evidences in budding 
yeast indicate that in the same DSB, Ligase 4 is recruited at the non-telomeric side, but not 
at the one bearing telomeric repeats (Fumagalli et al., 2012). Thus I can speculate that, 
upon the generation of a DSB within a telomere, the DDR signalling and repair factors 
recruitment are activated only on the distal DNA end. It follows that the telomere would 
result as DDR-positive because of the recruitment of DDR factors on one DNA end, yet it 
will resist repair because lack of a second available DNA end. Although enticing, this 
model is not easy to experimentally prove. Indeed, the concomitant targeting of TRF2 at 
both sides of a DSB in NIH 2/4 cells reduced the DDR activation initially upon break 
induction (Fig. 28), supporting the directionality model. However, after removal of the 
DNA damage agent and repair events, the presence of TRF2 on both DNA ends induced a 
more protracted DDR activation, similarly to that observed with only one TRF2-coated 
DNA end (compare Figs. 26 and 28).  
The second model is based on the ability of TRF2 to maintain the t-loop structure of 
telomeres (Amiard et al., 2007; Griffith et al., 1999; Stansel et al., 2001), preventing 
detection of the DNA end by MRE11 and activation of ATM in an indirect manner. I can 
speculate that the proximal part of a broken telomere loses the t-loop protection and thus 
elicits a DNA damage response, but still retains TRF2, which is able to inhibit NHEJ. This 
situation is reminiscent of the intermediate state telomere already described (Cesare et al., 
2013; Cesare et al., 2009) but it would be triggered by the loss of the t-loop structure rather 
than a decrease in TRF2 expression levels. This model is consistent with a recent report, 
elucidating the dual role of TRF2 in protecting telomeres (Okamoto et al., 2013). The lack 
of the TRFH dimerization domain of TRF2 induces DDR activation but no chromosomal 
fusions. This is due to the presence of a specific motif in the Hinge domain of TRF2, called 
inhibitor of DDR (iDDR) that inhibits the DDR cascade more downstream, at the level of 
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histone ubiquitylation by RNF8 and RNF168, thus impeding 53BP1 recruitment and NHEJ 
(Okamoto et al., 2013). Consistently RNF8 knock down has been shown to prevent 
chromosomal fusions in TRF2 depleted telomeres (Peuscher and Jacobs, 2011). Of note, 
the TRFH domain is involved in the t-loop formation (Amiard et al., 2007), supporting the 
model that the initial DDR activation is suppressed by the closed state, mediated by the 
TRFH domain of TRF2. 
Both models can fit with the key observation that a more persistent DDR activation is the 
result of an impaired DNA repair mediated by TRF2 (Fig. 32). Consequently, although 
valid and supported by some experimental evidences, no formal proof at the moment can 
confirm either model and further experiments are needed to shed light on the mechanisms 
fuelling protracted DDR activation at damaged telomeres.  
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5.3 Irreparable DNA damage at telomeres: a unifying mechanism for 
cellular senescence and ageing? 
5.3.1 Different types of cellular senescence are all triggered by telomeric DNA damage  
Historically cellular senescence has been intrinsically linked to telomeres, since replicative 
senescence is triggered by telomeric shortening (Harley et al., 1990). More recently, a role 
of telomeres has been described also in OIS (Suram et al., 2012). Replicative stress 
induced by RAS activation, causes replication fork stalling and accumulation of DNA 
damage preferentially at telomeres that behave like fragile sites. This DDR activation can 
be prevented by telomerase activity, and this leads to the escape from cell cycle arrest. 
Finally the experimental results presented here reveal that also exogenous sources of DNA 
damage, like IR, induce cellular senescence through persistent DDR activation at 
telomeres, which is not due to their shortening.  
Taken together, all these suggestions place again telomeres in a central role for the study of 
cellular senescence, and it is possible to propose that, independently from the stimulus  
(telomere shortening, oncogene-induced replication stress, exogenous DNA damage), the 
constantly activated DDR that causes and sustains the senescence status is due to telomere 
irreparability.	  	  
The existence of genomic regions that avoid repair is very dangerous for cell survival. 
However, inter-chromosome repair of telomeres would lead to fusions and consequent 
dicentric chromosomes that would trigger genomic instability and cancer initiation, thus in 
this particular loci, resisting DNA repair appears to be necessary. Taken together, these 
considerations indicate that, independently from the initial trigger, telomere irreparability 
and the resulting senescent establishment are an unavoidable drawback for protecting the 
end of linear chromosomes. 
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5.3.2 Ageing as a result of irreparable DNA damage at telomeres 
In the past years, many studies revealed that ageing is associated with DNA damage 
accumulation in a plethora of tissues in mice, baboons and humans (Dimri et al., 1995; 
Herbig et al., 2006; Jeyapalan et al., 2007; Nijnik et al., 2007; Rossi et al., 2007; Rube et 
al., 2011; Sedelnikova et al., 2004; Wang et al., 2009). In some cases this has been 
associated with dysfunctional telomeres (Herbig et al., 2006; Jeyapalan et al., 2007), but 
this is commonly interpreted as the outcome of telomere shortening. This conclusion is 
based on the fact that this phenotype has been observed in proliferating tissues and that 
telomere shortening in vivo is associated with impairment of stem cells and some features 
of ageing like hair greying, alopecia, defect in wound healing, as well as a reduction in the 
life span (Rudolph et al., 1999; Tumpel and Rudolph, 2012).  
Of note, I have showed that in post mitotic cells, like hippocampal neurons, DDR foci that 
accumulated with age in primates were not associated with the shortest telomeres (Figs. 
33,34). A similar result was reproduced also in liver, another non-proliferating 
compartment (Fumagalli et al., 2012), suggesting that telomeric shortening is not the only 
trigger for DDR accumulation in vivo.  
These data provide a mechanism for DDR- and senescence-mediated ageing of non-
proliferating tissues, which could not be explained solely by telomeric shortening. 
Accordingly to the model of irreparable DNA damage, during ageing telomere would 
accumulate persistent DDR markers following exposure to various sources of DNA 
damage, both endogenous (telomere shortening, ROS, replication stress, oncogene 
activation) or exogenous (UV, X-Rays), thus promoting cellular senescence and, at the 
organismal level, the ageing phenotype. Indeed, the DNA damage accumulated in post-
mitotic neurons in vivo in mice has been shown to promote a senescence-like state, as 
monitored by SA-β-gal positivity, heterochromatinization and high ROS and IL-6 
production (Jurk et al., 2012). In addition mitochondrial oxidative stress, can induce 
senescence and ageing in the epidermis (Velarde et al., 2012). 
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In turn deletion of p21, a p53 target in senescent cells, in telomerase-deficient mice rescues 
the maintenance of hematopoietic cells and intestinal epithelium (Choudhury et al., 2007). 
Similarly, clearance of p16-positive senescent cells in a mouse model can prevent and 
partially revert the establishment of age-related disorders (Baker et al., 2011), indicating 
that cellular senescence is causally implicated in tissue dysfunction and health span.  
The existence of genomic loci where DNA damage cannot be repaired would explain the 
appearance of senescent cells in vivo with age. This would lead to impaired cell 
replacement and consequent tissue, organ and organismal ageing. In summary, since the 
discovery of replicative senescence, telomeres have been considered as a biological clock, 
sensitive to the numbers of cell divisions. The novel results described here update this 
concept, and importantly extend this role also to the more abundant non-proliferating 
compartments in the organism, adding another mechanism for telomeres sensing the 
passing of time.  
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5.4 DDRNAs promote DDR and repair at dysfunctional telomeres  
5.4.1 DDRNAs as a novel component of DDR at uncapped telomeres 
The interest on non-canonical short ncRNAs such as DDRNAs in the DDR field is 
increasing and many studies indicate that they are implicated in signalling and repair in 
various models, including humans (Sharma and Misteli, 2013). The experimental results 
that I have showed suggest that also at uncapped telomeres DDRNAs are generated and 
they are necessary for the activation and maintenance of DDR (Figs. 35-38). The existence 
of short RNAs with G-rich telomeric sequence has already been reported in mouse 
embryonic stem cells (Cao et al., 2009). However they are DICER-independent, thus they 
seem to be totally unrelated to DDRNAs. 
This evidence gives more hints on the function of DDRNAs, because uncapped telomeres 
elicit a DDR that is slightly different from the canonical one at other genomic locations 
(Cesare et al., 2013). For instance, since telomeric DDR does not activate the G2/M 
checkpoint, it is possible that DDRNAs are mostly involved in the activation of the G1/S 
checkpoint.  
It can be argued that in TRF2-/- cells, telomeres are completely uncapped and also prone to 
chromosomal fusions, a situation that never occurs in physiological conditions. In 
senescent cells telomeres retain TRF2 that can inhibit repair events, thus it would be very 
interesting studying the impact of DDRNAs in the persistent DDR foci that accumulate at 
telomeres in IrrSen cells. A similar experiment has been already shown in OIS cells that 
express a constitutively active form of RAS oncogene; upon knock down of DICER or 
DROSHA, but not GW proteins, DDR foci disassemble and cell proliferation is re-
established (Francia et al., 2012). 
5.4.2 NHEJ at uncapped telomeres is dependent on DICER and DROSHA 
A more intriguing and less predicted result is the decrease in the number of chromosomal 
fusions in DICER and DROSHA knocked down cells (Fig 39). A role in DNA repair has 
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been already proposed for diRNAs both in plants and human cells, but limited to the HR 
pathway (Wei et al., 2012). An impact of DICER and DROSHA on chromosomal fusions 
suggests a role of DDRNAs also in NHEJ, which is the major DNA repair pathway acting 
at TRF2-depleted telomeres. Obviously further experiments are needed to clarify if this 
effect is DDRNA-mediated or instead it is an indirect effect of impaired miRNA 
biogenesis. For instance, it will be essential to demonstrate that inhibition of fusions is no 
more evident upon knock down of other downstream components of the miRNA 
biogenesis pathway, like GW proteins. Importantly, I also plan to treat cells with synthetic 
short DDRNAs with telomeric sequence, to show that they are sufficient to rescue the 
chromosomal fusions in DICER and DROSHA-depleted cells. Similarly, I will use 
antisense LNA oligonucleotides with the telomeric sequences, which I showed are able to 
counteract DDRNA-mediated DDR activation and proliferation arrest (Figs. 41,42), to 
inhibit DDRNAs in order to prevent chromosomal fusions.  
Since I showed that TRF2 is the main player in repair inhibition at telomeres, it would be 
very interesting to study the possible interaction between TFR2 and telomeric DDRNAs by 
cross-linking immunoprecipitation (CLIP) followed by high-throughput RNA sequencing, 
and, in case, also if it is necessary for the interruption of the downstream DDR events 
leading to DNA repair. Of note, TRF2 has already been shown to directly interact with 
another telomeric ncRNA, TERRA, through its amino terminal basic domain (Deng et al., 
2009). 
5.4.3 Telomeric DDRNAs as a target to prevent and revert cellular senescence and 
ageing phenotypes 
The evidence that DDRNAs generated at uncapped telomeres can be inhibited with 
antisense LNA molecules, to repress the DDR activation and rescue the senescence-
associated proliferation block (Figs. 40-42) opens a novel field of potential drug design for 
many diseases. 
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Indeed recently, many reports show that small ncRNAs can be inhibited even in vivo by 
different antisense oligonucleotides (ASOs), which act through base pairing 
complementarity, and thus used as targets of therapeutic strategies (Esteller, 2011). They 
have been mainly used to repress miRNAs activity in different diseases in mouse models. 
For instance in mammary tumours, antagomir targeting miR-10b suppresses metastasis 
formation (Ma et al., 2010), while LNAs have been used to reduce melanoma metastasis 
(Pencheva et al., 2012). LNAs have been successfully used in other pathologies like acute 
myocardial infarction and obesity (Boon et al., 2013; Grueter et al., 2012). Also in 
primates LNAs have been used to treat deregulated cholesterol metabolism and chronic 
hepatitis C virus infection (Elmen et al., 2008; Lanford et al., 2010). 
Based on these encouraging findings, it would be very interesting to test antisense LNAs in 
vivo, in a mouse model with impaired telomere maintenance, in order to study the efficacy 
of the treatment on senescence and ageing phenotypes. This would lead to the design of 
drugs for human diseases linked to telomeric dysfunction, as well as to treat all the 
phenotypes caused by DDR accumulation at telomeres during ageing.  
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